Medical Devices

Baculovirus Expression System Market to Reach USD 731.3 million by 2032, driven by the increasing demand for protein therapeutics and vaccines: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global  Baculovirus Expression System Market is expected to grow rapidly over the next 10 years to reach a value of more than USD 731.3 million by 2032.

The Baculovirus Expression System is a widely utilized biotechnological tool for protein expression in insect cells. It involves the use of baculoviruses, which are insect-specific viruses, as vectors to introduce and express foreign genes in insect cell cultures. This system is particularly valuable for the production of complex eukaryotic proteins, including those with post-translational modifications, making it a preferred choice in biopharmaceutical research and protein expression studies. The Baculovirus Expression System offers a versatile and efficient platform for the synthesis of recombinant proteins with diverse applications, ranging from academic research to the development of vaccines and therapeutic proteins.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS26618/

 Baculovirus Expression System Market: Key Trends and Drivers

The Baculovirus Expression System (BEVS) market is primarily driven by its widespread utilization in the production of recombinant proteins for various applications, ranging from research and development to large-scale biopharmaceutical manufacturing. The system’s versatility, scalability, and ability to achieve high protein yields in insect cells make it a preferred choice for expressing complex proteins that may be challenging to produce in other systems. Additionally, the Baculovirus Expression System offers advantages such as post-translational modifications similar to those in mammalian cells, ensuring proper folding and functionality of expressed proteins. The increasing demand for biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins, further propels the growth of the Baculovirus Expression System market. With ongoing advancements in genetic engineering and cell culture technologies, the market is poised for continuous expansion, catering to the evolving needs of the biotechnology and pharmaceutical industries.

 Baculovirus Expression System Market: Restraints and Challenges

One prominent limitation is the inherent complexity and time-consuming nature of the Baculovirus vector construction process. Designing and generating recombinant Baculoviruses often involves multiple steps, including DNA manipulation and virus propagation, leading to a relatively lengthy production timeline. Additionally, the scalability of Baculovirus-based expression systems can pose challenges, especially for large-scale industrial applications, where alternative expression platforms may offer more straightforward scalability. Overcoming these hurdles through advancements in vector engineering, optimization of production processes, and the development of user-friendly systems could enhance the competitiveness and broader adoption of Baculovirus Expression Systems in the biotechnology industry..

 Baculovirus Expression System Market Report Findings

https://www.globalinsightservices.com/reports/baculovirus-expression-system-market/

The largest and fastest-growing market category is Expression Vector segment

On the basis of Product Type, the Baculovirus Expression System Market is segmented into Baculovirus, Expression Vector, Reagents, and Others. Among these , in 2022, Expression Vector has witnessed substantial expansion, driven by the  increasing demand for efficient protein expression in various biopharmaceutical and research applications. Researchers and biotechnologists have favored Baculovirus Expression Systems for their ability to produce complex proteins, post-translational modifications, and proper protein folding. The versatility of Expression Vectors in facilitating the expression of a wide range of proteins has contributed significantly to the overall growth of the Baculovirus Expression System market. However, for the latest and most specific information, I recommend checking the latest market reports or industry publications as of your current date in December 2023.

The largest and fastest-growing market category is Therapeutics segment

Based on application, the Baculovirus Expression System Market is segmented into Therapeutics, Vaccines, Protein Purification, and Others. Out of these, in 2022, Therapeutics segment emerging as a key contributor to this expansion. The therapeutic applications of BEVS have gained considerable traction, particularly in the production of biopharmaceuticals and gene therapy vectors. The system’s ability to efficiently express complex proteins and ensure proper post-translational modifications has positioned it as a preferred choice for therapeutic protein production. Additionally, its versatility in accommodating diverse therapeutic targets, coupled with advancements in bioprocessing technologies, has further fueled its prominence in the Therapeutics segment. As the Baculovirus Expression System celebrates its one-year milestone, its sustained expansion within the therapeutic realm underscores its pivotal role in advancing biopharmaceutical development and holds promise for continued innovation in the coming years.

The largest and fastest-growing market category is Biopharmaceutical Companies segment

Based on end-user, the Baculovirus Expression System Market is bifurcated into Biopharmaceutical Companies, Research Institutes, Others. Among  these, in 2022,  the Biopharmaceutical Companies segment in the Baculovirus Expression System Market has witnessed remarkable growth, due to an increasing demand for efficient and scalable protein expression platforms. Biopharmaceutical companies, in particular, are embracing the Baculovirus Expression System for its ability to produce complex proteins with post-translational modifications, closely resembling those found in mammalian cells. This system offers a versatile and cost-effective solution for the production of vaccines, gene therapies, and recombinant proteins, making it an attractive choice for biopharmaceutical research and development. The segment’s growth is further propelled by the continuous refinement of Baculovirus Expression System technologies, providing enhanced yields and facilitating the production of biologics critical for advancing therapeutic solutions in the evolving landscape of biopharmaceuticals.

Geographical Analysis of  Baculovirus Expression System Market

Based on end-user, the Baculovirus Expression System Market is bifurcated into Biopharmaceutical Companies, Research Institutes, Others. Among  these, in 2022,  the Biopharmaceutical Companies segment in the Baculovirus Expression System Market has witnessed remarkable growth, due to an increasing demand for efficient and scalable protein expression platforms. Biopharmaceutical companies, in particular, are embracing the Baculovirus Expression System for its ability to produce complex proteins with post-translational modifications, closely resembling those found in mammalian cells. This system offers a versatile and cost-effective solution for the production of vaccines, gene therapies, and recombinant proteins, making it an attractive choice for biopharmaceutical research and development. The segment’s growth is further propelled by the continuous refinement of Baculovirus Expression System technologies, providing enhanced yields and facilitating the production of biologics critical for advancing therapeutic solutions in the evolving landscape of biopharmaceuticals.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS26618/

Competitive Landscape

The key players studied in the report are Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek,  among others.

Recent Developments

• In April 2023, Promega Corporation launched the pFastBac Dual Baculovirus Expression System, which is a system for the production of two recombinant proteins in insect cells from a single vector. The system includes a new vector, a new insect cell line, and a transfection reagent.
• In March 2023, Oxford Expression Technologies launched the AcMNPV BaculoDirect Expression System, which is a system for the rapid and efficient production of recombinant proteins in insect cells. The system includes a new vector, a new insect cell line, and a transfection reagent.
• In February 2023, Thermo Fisher Scientific launched the BaculoDirect Baculovirus Expression System, which is a streamlined system for the production of recombinant proteins in insect cells. The system includes a new vector, transferrin receptor-mediated transfection (TRMT) technology, and a new Sf9 insect cell line.
• In April 2022, Thermo Fisher Scientific partnered with Watchmaker Genomics to improve AAV production for gene therapy using the Thermo Fisher Baculovirus Expression Vector System.
• In June 2021, Aragen Bioscience acquired Exelead’s CMO business to expand its biologics and viral vector CDMO capabilities including baculovirus-insect cell expression platforms.
• In May 2020, Sartorius acquired a majority stake in cell culture media expert Biological Industries. This enhanced Sartorius’ expertise in insect cell culture media for baculovirus expression.

 Baculovirus Expression System Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current  Baculovirus Expression System Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of  Baculovirus Expression System Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Solar Vehicle Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the  Baculovirus Expression System Market along with the current trends and future estimations to depict imminent investment pockets. The overall Solar Vehicle industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the  Baculovirus Expression System Market are also analyzed.

Global  Baculovirus Expression System Market Segmentation

By Product Type

• Baculovirus
• Expression Vector
• Reagents
• Others

By Application

• Therapeutics
• Vaccines
• Protein Purification
• Others

By End User

• Biopharmaceutical Companies
• Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Takara Bio (Part of Otsuka Holdings)
• Agilent Technologies
• Oxford Expression Technologies
• Promega Corporation
• Qiagen N.V.
• Bio-Rad Laboratories
• New England Biolabs
• Genscript Biotech Corporation
• Syngene International Limited
• Sartorius AG (BIA Separations)
• Aragen Bioscience
• Vivopure
• Creative Biogene
• Absolute Antibody
• Rockland Immunochemicals
• Protein Technologies, Inc. (PTI)
• Proteogenix
• Virovek

Bioprocess Bags Market to Reach USD 11.3 Billion by 2032, driven by the growth in advancements in bioprocess technology, such as single-use systems and disposable bioprocess bags, and the increasing adoption of modular manufacturing: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global Bioprocess Bags Market is expected to grow rapidly over the next 10 years to reach a value of more than USD 11.3 billion by 2032.

Bioprocessing bags are a flexible and customisable solution used for the safe handling of liquids within a bioprocess environment. Bioprocessing bags are used from small-scale research through to full-scale production. These bags are commonly used for the storage, transport, and handling of liquids such as blood, pharmaceutical solutions, and other biopharmaceutical substances. Featuring a flexible and single-use design, bioprocess bags offer advantages in terms of minimizing contamination risks and providing a convenient and cost-effective solution for various medical applications. They play a crucial role in maintaining the integrity of biological materials during manufacturing processes and are particularly prevalent in biopharmaceutical production for their adaptability and ease of use..

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/

Bioprocess Bags Market: Key Trends and Drivers

A significant market driver for the Bioprocess Bags Market is the escalating demand for biopharmaceuticals and the subsequent need for efficient and flexible single-use bioprocessing solutions. Bioprocess bags offer advantages such as reduced risk of cross-contamination, lower cleaning and validation costs, and increased flexibility in manufacturing processes, which align with the growing trend toward modular and flexible production in the biopharmaceutical industry. The increasing focus on cost-effectiveness, speed, and scalability in bioprocessing operations has spurred the adoption of single-use systems, with bioprocess bags emerging as a key component. Additionally, the ability of bioprocess bags to cater to a wide range of applications, from cell culture and fermentation to media storage and transportation, positions them as a versatile and indispensable solution, further propelling the growth of the Bioprocess Bags Market.

The surging demand for biologics, including vaccines, monoclonal antibodies, and gene therapies, particularly for applications like cancer treatment, has directly shaped the trajectory of the bioprocess bags market. Biologics, encompassing drugs and therapeutics developed to address diverse diseases, have witnessed a growing need, and the bioprocess bags market is responding to this demand. The market is further influenced by advancements in healthcare technology, contributing to exponential growth. Notably, bioprocess bags play a role in sustainability efforts by minimizing unnecessary water usage. An illustrative example is the collaboration between Samsung Biologics and AstraZeneca in September 2020, where they joined forces to produce extensive medicinal materials and bioprocessing machinery, primarily focusing on cancer therapy and addressing the demands arising from the COVID-19 pandemic in 2021.

Bioprocess Bags Market: Restraints and Challenges

The bioprocess bags market, while witnessing significant growth, faces certain restraints that impede its full potential. One notable limitation is the concerns regarding the leaching of substances from the plastic materials used in bioprocess bags into the biopharmaceutical products they contain. As the industry demands high purity and stringent quality standards, any potential interaction between the plastic components of the bags and the sensitive biologics poses a challenge. Regulatory scrutiny on the materials used in these bags, coupled with the need for thorough validation processes, adds complexity and cost to manufacturing. such factors will hinders the industry growth during forecast timeframe.

Bioprocess Bags Market Report Findings

https://www.globalinsightservices.com/reports/bioprocess-bags-market/

The largest and fastest-growing market category is 2D Bioprocess Bags

On the basis of Type, the Bioprocess Bags Market is segmented into 2D Bioprocess Bags, 3D Bioprocess Bags, and Other Bags & Accessories.  The 2D bioprocess bag segment led the market in 2022, driven by the increasing demand for biopharmaceuticals and cell therapies. Rising cases of chronic diseases, such as cancer, diabetes, and autoimmune disorders, have elevated the need for innovative treatments, with biopharmaceuticals emerging as a promising solution. The use of 2D bioprocess bags streamlines the manufacturing process, contributing to cost reduction. This segment’s growth is further fueled by ongoing technological advancements in bag design and materials, with manufacturers focusing on enhancing strength, durability, and resistance to punctures and leaks. Additionally, a trend toward customization and scalability is evident as bags are tailored to meet the specific requirements of diverse bioprocessing applications.

Simultaneously, the 3D bioprocess bags segment is anticipated to witness the fastest Compound Annual Growth Rate (CAGR) during the forecast period. Commonly employed in the production and storage of biologics, such as monoclonal antibodies, vaccines, and cell-based therapies, these bags provide a closed and sterile environment for cell culture, reducing the risk of contamination and ensuring the quality and consistency of the end product. The segment’s growth is further propelled by the increasing demand for regenerative medicine and substantial government funding initiatives. Notably, initiatives like the Regenerative Medicine Innovation Project (RMIP), introduced in 2021 by the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA), aim to support the development of safe and effective regenerative medicine products, guide industry stakeholders with best practices, and encourage robust product development to ensure patient safety.

The largest and fastest-growing market category is Upstream Process

Based on workflow, the Bioprocess Bags Market is segmented into Upstream Process, Downstream Process, and Process Development. In 2022, the upstream process segment emerged as the dominant force in the bioprocess bags market. These bags are widely used in cell culture, media preparation, and fermentation processes, creating a sterile and controlled environment that optimizes cell growth and productivity. With various sizes and attributes, bioprocessing bags meet the growing demand for biopharmaceuticals and vaccines, driven by factors such as the industry shift towards single-use technologies and the advantages of disposability in terms of cost-effectiveness, efficiency, and risk reduction. This dominance is evident in the initial stages of bioprocessing, where bioprocess bags, also known as single-use bags, are increasingly preferred over traditional stainless-steel bioreactors due to their ease of use.

Meanwhile, the downstream process segment is poised for significant growth during the forecast period. In this phase, bioprocess bags play a crucial role in storing and transporting the product during various purification stages. Offering advantages such as lower contamination risk, reduced cleaning and validation requirements, and faster turnaround times compared to traditional stainless-steel vessels, bioprocess bags are gaining traction. For instance, Sartorius AG’s flexsafe bags, available in various sizes, serve as a complete single-use solution for downstream bioprocessing when used with Sartorius’ flexboy and flexboy Advance disposable bioreactors.

The largest and fastest-growing market category is Pharmaceutical & Biopharmaceutical Companies

Based on end-user, the Bioprocess Bags Market is bifurcated into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs, and Academic & Research Institutes. In 2022, the pharmaceutical and biopharmaceutical companies segment held a significant market share. Key players strategically pursued expansion, new product launches, mergers, acquisitions, and collaborations, creating lucrative opportunities. For instance, in February 2021, Saint-Gobain introduced highly efficient cell culture bags designed for T-cell expansion, contributing to sterile and controlled environments crucial for T-cell growth—a vital component in immune system-based therapies. This segment is anticipated to sustain its dominance, fueled by ongoing investments by pharmaceutical companies in new drug development, thereby driving the demand for bioprocess bags. Another promising growth segment is biopharmaceuticals, where the production of living cell-based drugs necessitates specialized equipment and materials for maintaining integrity and purity throughout the manufacturing process. Bioprocess bags offer advantages over traditional stainless-steel tanks, including cost savings, improved product quality, and reduced contamination risk. As the development of biopharmaceuticals rises, the demand for specialized equipment such as bioprocess bags is expected to increase. Collaborations with bag manufacturers, investment in new materials or production techniques, and funding for research and development are among the strategies likely to be pursued by pharmaceutical companies in this context.

However, the CMOs and CROs segment is poised for robust growth, driven by the adoption of contract services, offering scalability, flexibility, reduced internal infrastructure requirements, and dedicated supply channels. The outsourcing trend enables companies to enhance efficiency, reduce costs, and focus on core competencies, contributing to the expansion of the bioprocess bags market.

Geographical Analysis of Bioprocess Bags Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The bioprocess bags market is currently dominated by North America, where substantial revenue is generated. The region boasts a concentration of major pharmaceutical companies, prompting significant investments in biopharmaceutical products that require effective handling of tissues and cells, a task for which bioprocess bags are essential. This has resulted in a diverse range of bioprocess bags being available, catering to the rising demand for monoclonal antibodies, vaccines, and other biologics. Notably, the American Cancer Society predicts a substantial increase in new cancer cases (1,958,310) and cancer-related deaths (609,820) in the United States in 2023. This surge in health challenges is expected to drive the demand for bioprocess bags in the market, particularly as they play a crucial role in preventing contamination during the production of biologics.

Asia-Pacific emerges as the fastest-growing region in the bioprocess bags market, driven by a surge in life science research, the flourishing biopharmaceutical industry, and increasing investments in pharmaceutical biotechnology enterprises. The region has witnessed significant growth in its biopharmaceutical sector, leading to an upswing in the demand for bioprocess bags. This demand is further propelled by the increasing need for personalized medicine, necessitating the production of smaller drug batches and consequently driving the requirement for single-use bioprocess bags. These bags offer a more flexible and cost-effective alternative to conventional stainless-steel bioreactors. The burgeoning population with heightened healthcare requirements is expected to be a primary growth catalyst. Additionally, escalating investments in the biopharmaceutical sector by governments and private investors in countries like China, Japan, and South Korea are anticipated to significantly contribute to the rising demand for bioprocess bags in the region.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/

Competitive Landscape

The key players studied in the report are  Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Merck KGaA, Saint-Gobain, Corning Incorporated, Entegris, Meissner Filtration Products Inc., PROAnalytics LLC, and CellBios Healthcare And Lifesciences Pvt Ltd., among others.

Recent Developments

• In April 2022, Thermo Fischer Scientific, Inc. announced the opening of a new manufacturing facility in Ogden, Utah, that will manufacture materials and technology needed for the development of new vaccines and therapies. The facility is part of Thermo Fisher’s investment of USD 650 million to ensure a reliable bioprocessing production capacity for crucial materials used in creating biologics and vaccines, including COVID-19 vaccines. This investment will enable the company to meet the increasing demand for single-use technology and contribute to the development of innovative therapies and vaccines.
• In July 2021, Pall Corporation announced a contract with Exothera S.A., valued at approximately $7 million. This new agreement is intended to create a suspension-based manufacturing platform capable of producing up to 2000L of product. The platform will utilize a range of technologies including Allegro STR single-use bioreactors to produce various viral vectors used in gene therapies and viral vector-based vaccines.
• In February 2021, Saint-Gobain announced the launch of highly efficient cell culture bags for T-cell expansion. These new cell culture bags are designed to provide a sterile and controlled environment for the growth and expansion of T-cells, which are an essential component of the immune system and are used in cell-based therapies for the treatment of various diseases.
• in 2021, The Regenerative Medicine Innovation Project (RMIP) was introduced in collaboration between the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The program supports the development of safe and effective regenerative medicine products. It also guides various industry stakeholders with information on best practices and the development of new tools and standards for evaluating regenerative medicine products. The program also encourages robust product development to ensure patient safety.

Bioprocess Bags Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Bioprocess Bags Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Bioprocess Bags Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Bioprocess Bags Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Bioprocess Bags Market along with the current trends and future estimations to depict imminent investment pockets. The overall Bioprocess Bags industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Bioprocess Bags Market are also analyzed.

Global Bioprocess Bags Market Segmentation

By Type

• 2D Bioprocess Bags
• 3D Bioprocess Bags
• Other Bags & Accessories

By Workflow

• Upstream Process
• Downstream Process
• Process Development

By End-user

• Pharmaceutical & Biopharmaceutical Companies
• CMOs & CROs
• Academic & Research Institutes

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Danaher Corporation
• Merck KGaA
• Saint-Gobain
• Corning Incorporated
• Entegris
• Meissner Filtration Products, Inc.
• PROAnalytics, LLC
• CellBios Healthcare And Lifesciences Pvt Ltd.

Medical Health Screening Services Market to Reach USD 41.8 Billion by 2032, driven by the Government funding and initiatives to promote routine health check-ups and make screening services affordable: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global Medical Health Screening Services Market is expected to grow rapidly over the next 10 years to reach a value of more than USD 41.8 billion by 2032.

Medical health screening services encompass a variety of diagnostic tests designed to identify diseases and evaluate an individual’s overall health condition. These screenings play a crucial role in early disease detection, allowing for timely intervention and improved health outcomes by identifying potential health issues before symptoms manifest. The primary benefit of medical screening lies in its capacity to promote proactive healthcare rather than a reactive approach, emphasizing preventive measures and facilitating early intervention strategies. These services often involve a comprehensive assessment of various health parameters, contributing to a holistic understanding of an individual’s well-being.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/

Medical Health Screening Services Market: Key Trends and Drivers

The increasing emphasis on preventive healthcare and early disease detection. With a rising awareness of the importance of proactive health management, individuals and healthcare providers alike are recognizing the value of regular health screenings to identify potential health issues at an early stage. Early detection not only enhances the effectiveness of treatment but also reduces overall healthcare costs by mitigating the need for extensive and expensive interventions at advanced disease stages. Moreover, advancements in medical technology and the availability of a diverse range of non-invasive screening tests contribute to the market’s expansion, making health screenings more accessible and appealing to a broader population. As healthcare systems worldwide shift towards a preventive care paradigm, the demand for medical health screening services is expected to continue growing, driving market expansion in the foreseeable future.

Medical Health Screening Services Market: Restraints and Challenges

One significant market restraint and challenge facing the Medical Health Screening Services Market is the persistent issue of inadequate accessibility and affordability, particularly in developing regions. The implementation of comprehensive health screening services requires significant infrastructure, trained healthcare professionals, and advanced diagnostic technologies, which may be lacking in certain geographies. This creates a disparity in healthcare access, hindering the widespread adoption of medical health screening services and exacerbating healthcare inequalities. Additionally, the high costs associated with state-of-the-art screening technologies and procedures pose a financial barrier for a considerable portion of the population. This economic challenge limits the market’s potential for growth and hampers efforts to establish widespread preventive healthcare practices, ultimately impeding the overall progress of the Medical Health Screening Services Market. Addressing these accessibility and affordability issues will be crucial for the market to realize its full potential and contribute effectively to global healthcare outcomes.

Medical Health Screening Services Market Report Findings

https://www.globalinsightservices.com/reports/medical-health-screening-services-market/

The largest and fastest-growing market category is Routine Tests

On the basis of Test Type, the Medical Health Screening Services Market is segmented into Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, and Others. In 20222, routine tests play a pivotal role in driving the robust growth observed in the Market. As an integral component of preventive healthcare, routine tests encompass a wide array of screenings that aim to detect potential health issues at their nascent stages, enabling timely intervention and management. The increasing awareness and emphasis on proactive health management among individuals have led to a surge in demand for routine health screenings. These tests often include blood pressure monitoring, cholesterol checks, blood glucose assessments, and other baseline evaluations, forming a critical foundation for comprehensive health assessments. The burgeoning adoption of routine tests underscores their significance in preventive healthcare, contributing substantially to the expansion of the Medical Health Screening Services Market.

The largest and fastest-growing market category is Blood

Based on sample type, the Medical Health Screening Services Market is bifurcated into Blood, Urine, Saliva, and Others. The Medical Health Screening Services Market has witnessed a notable surge in demand for blood-based screening services, reflecting a robust growth in the blood segment in 2022. This trend can be attributed to the increasing awareness of preventive healthcare, prompting individuals to undergo comprehensive blood screenings for early detection of various medical conditions. With advancements in diagnostic technologies, blood tests offer a non-invasive and efficient means of assessing an individual’s overall health, ranging from cholesterol levels to markers for diabetes and infectious diseases. The growing emphasis on proactive health management and the role of blood biomarkers in personalized medicine are driving the expansion of blood-based medical health screening services, making it a pivotal contributor to the market continued expansion.

The largest and fastest-growing market category is Hospitals/Clinical Laboratories

Based on setting type, the Medical Health Screening Services Market is segmented into Hospitals/Clinical Laboratories, Workplaces, Ambulatory Care Centers, Diagnostic Imaging Centers, and Others. in 2022, hospitals/clinical Llaboratories segment is profoundly influenced by the evolving healthcare setting. As healthcare systems worldwide prioritize preventive measures and early detection, the demand for medical health screening services within hospitals and clinical laboratories has surged. These settings provide a comprehensive infrastructure for diagnostic procedures, attracting a diverse patient base seeking routine screenings and specialized tests. The integration of advanced technologies, coupled with the increasing awareness of the importance of regular health check-ups, further propels the growth of this segment. Moreover, the pivotal role played by hospitals and clinical laboratories in managing and interpreting screening results fosters trust among patients, contributing significantly to the sustained expansion of the Medical Health Screening Services Market within this specific setting.

Moreover, The growth of the Hospitals/Clinical Laboratories segment in the Medical Health Screening Services Market is significantly bolstered by the escalating investment in hospital settings and the well-developed infrastructure, particularly in developed countries. Developed nations have witnessed substantial financial commitments to healthcare infrastructure, resulting in state-of-the-art hospitals and clinical laboratories equipped with advanced diagnostic technologies. This robust infrastructure not only facilitates the seamless integration of medical health screening services but also attracts substantial investments in cutting-edge screening technologies. The availability of well-established facilities fosters a conducive environment for the expansion of screening services, attracting both patients and healthcare providers. Hence, driving growth in the Hospitals/Clinical Laboratories segment will propel the Medical Health Screening Services Market.

Geographical Analysis of Medical Health Screening Services Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, Asia-Pacific region has witnessed robust growth in the Medical Health Screening Services Market due to several key factors. Increasing awareness about preventive healthcare, rising healthcare expenditure, and a growing aging population as well as the rising prevalence of chronic diseases have fueled the demand for medical health screening services. Governments and private healthcare organizations in the region are actively promoting early disease detection and management, driving the adoption of screening services. Moreover, the prevalence of lifestyle-related diseases and the desire for a healthier lifestyle have spurred individuals to proactively seek preventive healthcare measures, further contributing to the market’s expansion. The evolving healthcare infrastructure, technological advancements, and the integration of innovative diagnostic tools have also played a pivotal role in enhancing the accessibility and efficiency of health screening services, making them more appealing to a broader population in the Asia-Pacific region.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/

Competitive Landscape

The key players studied in the report are  Quest Diagnostics, Eurofins Scientific, SYNLAB International, Sonic Healthcare, LabCorp, Unilabs, Lifelabs, Healthscope, Clinical Reference Laboratory, and ACM Medical Laboratory among others.

Recent Developments

• In May 2023, Index Medical Systems, a healthcare company received regulatory approval from the National Medical Products Administration (NMPA), China to launch over 30 medical tests in the areas of oncology, women’s health, and general wellness screening in China. These will allowIndex to tap into China’s large preventive healthcare screening industry and provide quality healthcare services to more Chinese citizens.
• In July 2022, Bloom Diagnostics, a medtech startup launched its new Bloom Inflammation Test, which measures C-reactive protein (CRP) in the bloodstream to detect inflammation in the body.
• In May 2022, QIAGEN NV, provider of sample and assay technologies for molecular diagnostics launched the QIAstat Dx Rise and advanced panels. QIA stat-Dx Rise and its test cartridges are a closed system for manual sample preparation and processing.
• In January 2022, health screening provider Practo, a mhealth platform launched diabetes screening services across various cities in India. Practo started providing HbA1c, fasting and post-meal blood sugar screening at affordable prices through a network of partner labs. This expanded Practo’s preventive health screening portfolio and enabled more accessibility to diabetes screening services in India
• In June 2021, Grail, a healthcare company introduced the Galleri diagnostic, a single blood test capable of detecting the presence of numerous malignancies. The test is intended to check patients who are already at a high risk of cancer, such as persons over the age of 50.

Medical Health Screening Services Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Medical Health Screening Services Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Medical Health Screening Services Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Medical Health Screening Services Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Medical Health Screening Services Market along with the current trends and future estimations to depict imminent investment pockets. The overall Medical Health Screening Services industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Medical Health Screening Services Market are also analyzed.

Global Medical Health Screening Services Market Segmentation

By Test Type

• Routine Tests
• Non-Routine Tests
• Cancer Screening Tests
• Specialty Tests
• Others

By Sample Type

• Blood
• Urine
• Saliva
• Others

By Setting Type

• Hospitals/Clinical Laboratories
• Workplaces
• Ambulatory Care Centers
• Diagnostic Imaging Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Quest Diagnostics
• Sonic Healthcare
• LabCorp
• Unilabs
• Eurofins Scientific
• SYNLAB International
• Lifelabs
• Healthscope
• Clinical Reference Laboratory
• ACM Medical Laboratory

Nasal Splints Market to Reach USD 3.63 Billion by 2032, driven by the growing prevalence of nasal disorders: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global Nasal Splints Market is expected to grow rapidly over the next 10 years to reach a value of more than USD 3.63 billion by 2032.

Nasal splints are medical devices used to stabilize and support the nasal septum after nasal surgeries such as septoplasty and rhinoplasty.Nasal splints are medical devices designed to support and stabilize the nasal septum or nasal passages. Typically used post-nasal surgery, these splints aid in maintaining proper alignment, reducing the risk of complications such as septal deviations or collapse. They provide structural support during the healing process, helping to prevent adhesions and ensuring optimal airflow. Nasal splints can be composed of various materials, including silicone or absorbable materials, and are essential tools in promoting effective recovery and long-term nasal health.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/

Nasal Splints Market: Key Trends and Drivers

The Nasal Splints Market is primarily driven by a growing prevalence of nasal disorders, such as deviated septum, nasal fractures, and chronic nasal congestion, globally. The increasing awareness among healthcare professionals and patients regarding the benefits of nasal splints in facilitating postoperative recovery, reducing nasal obstruction, and preventing complications after nasal surgeries contributes significantly to market growth. Additionally, advancements in technology, such as the development of innovative materials and designs for nasal splints, are enhancing their efficacy and patient comfort, further propelling market expansion. Moreover, the rising demand for minimally invasive surgical procedures and an aging population prone to nasal conditions are key demographic factors fostering market growth. As healthcare systems continue to prioritize patient outcomes and quality of life, the Nasal Splints Market is poised for sustained growth in the foreseeable future.

Nasal Splints Market: Restraints and Challenges

The Nasal Splints Market faces several significant restraints that impact its growth and adoption. One key limitation is the discomfort and inconvenience associated with prolonged usage of nasal splints, especially in the postoperative period. Patients often report discomfort, irritation, and difficulty in breathing, leading to reduced compliance with the prescribed treatment. Additionally, the aesthetic concerns related to the visible presence of nasal splints may deter some individuals from opting for this intervention. Moreover, the Nasal Splints Market is hindered by the limited awareness among both healthcare professionals and patients regarding the benefits of nasal splints in various nasal conditions. This lack of awareness can result in underdiagnosis and underutilization of nasal splints, restricting market expansion. Furthermore, economic factors, including the high cost of certain nasal splint devices, pose a financial barrier for some patients, limiting market penetration. Addressing these restraints through innovative product development, education campaigns, and cost-effective solutions will be crucial for the sustained growth of the Nasal Splints Market.

Nasal Splints Market Report Findings

https://www.globalinsightservices.com/reports/nasal-splints-market/

The largest and fastest-growing market category is Malleable Nasal Splints

On the basis of Product Type, the Nasal Splints Market is segmented into Malleable Nasal Splints, Airway Nasal Splints, Bivalve Nasal Splints, Septal Nasal Splints, and Others. Malleable nasal splints represent a significant segment within the Nasal Splints Market, offering a versatile solution for various nasal conditions. These splints, characterized by their flexibility and adaptability, play a crucial role in supporting and maintaining nasal structures. Designed to be easily moldable, they provide a customized fit for individual patients, ensuring optimal comfort and efficacy in the treatment of nasal issues such as septal deviations or postoperative support. The demand for malleable nasal splints is driven by their ability to conform to diverse nasal anatomies, promoting patient-specific therapeutic outcomes and contributing to the overall growth and innovation in the Nasal Splints Market.

The largest and fastest-growing market category is Intranasal Splints

Based on Mechanism, the Nasal Splints Market is bifurcated into Intranasal Splints, and External Nasal Splints. In 2022, intranasal splints, also known as nasal splints, play a crucial role in the medical field, particularly in rhinoplasty and septoplasty procedures. These devices are designed to support and maintain the shape of the nasal passages, aiding in postoperative healing and preventing complications such as adhesions and collapse. The mechanism of intranasal splints involves providing structural support to the nasal framework, reducing the risk of deformities and ensuring optimal airflow. Typically made from biocompatible materials, these splints are inserted into the nasal cavity during surgery and contribute to the overall success of nasal procedures by promoting proper tissue alignment and minimizing trauma. As an integral component in nasal surgery, the intranasal splints market continues to evolve with advancements in material technology and surgical techniques, enhancing patient outcomes and recovery experiences.

The largest and fastest-growing market category is Biodegradable Nasal Splints

Based on material, the Nasal Splints Market is bifurcated into Biodegradable Nasal Splints, and Non-biodegradable Nasal Splints. In 2022, biodegradable nasal splints have emerged as a notable trend in the nasal splints market, reflecting a growing emphasis on environmentally friendly medical solutions. These splints, typically crafted from biocompatible and biodegradable materials, offer a temporary support structure for the nasal airways during the postoperative phase of rhinoplasty or nasal surgery. The shift towards biodegradable alternatives underscores the healthcare industry’s commitment to sustainability, minimizing the environmental impact associated with medical interventions. This innovation not only addresses patient comfort and recovery but also aligns with the broader global effort to reduce non-biodegradable waste in healthcare practices. As the demand for eco-friendly medical devices rises, biodegradable nasal splints are likely to play a pivotal role in shaping the future landscape of nasal splint technologies.

The largest and fastest-growing market category is Plastic Surgeries

Based on application, the Nasal Splints Market is bifurcated into Plastic Surgeries, Rhinoplasty, Deviated Septum, Nasal Fractures, and Others. In 2022, the Plastic Surgeries of Nasal Splints Market is witnessing a surge in demand owing to the increasing prevalence of nasal deformities and the growing preference for aesthetic enhancements. These nasal splints find application in various plastic surgery procedures, such as rhinoplasty and septoplasty, providing structural support, shape retention, and post-operative stability to the nasal framework. The rising awareness about cosmetic procedures and advancements in surgical techniques are driving the adoption of nasal splints, contributing to the market’s expansion. Moreover, the market is propelled by the rising number of plastic surgeries globally and the continuous innovation in material technologies, ensuring improved patient outcomes and enhanced comfort during the recovery phase.

The largest and fastest-growing market category is Hospital & Clinics

Based on setting type, the Nasal Splints Market is segmented into Hospital & Clinics, Homecare, Research Centers, Ambulatory Surgical Centers, and Others. In 2022, the hospital & clinics segment driven by the needs of end-users such as healthcare facilities, reflects a growing demand for effective solutions in nasal care. Nasal splints play a crucial role in postoperative management, aiding in the stabilization of nasal structures and supporting optimal healing. Hospitals and clinics are increasingly adopting these devices to address a spectrum of nasal conditions, ranging from post-surgical recovery to trauma management. The market’s trajectory is influenced by a rising awareness among healthcare professionals about the benefits of nasal splints, coupled with advancements in product design and materials, ensuring enhanced patient comfort and improved outcomes. As medical institutions prioritize patient well-being, the Hospital & Clinics Nasal Splints Market is positioned to witness continued growth as an integral component of comprehensive nasal healthcare strategies.

Geographical Analysis of Nasal Splints Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America Nasal Splints Market is characterized by a robust demand for innovative and effective nasal splint solutions. The region’s healthcare landscape, marked by advanced medical infrastructure and a high prevalence of nasal-related issues, propels the market’s growth. Factors such as increasing awareness about nasal deformities, rising incidence of nasal injuries, and a growing emphasis on post-operative care contribute to the expanding market. Additionally, technological advancements in nasal splint design and materials further drive market dynamics. With a focus on patient comfort and rapid recovery, healthcare providers and manufacturers in North America are actively collaborating to introduce cutting-edge nasal splint solutions, making this market a pivotal hub for advancements in nasal healthcare.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/

Competitive Landscape

The key players studied in the report are Network Medical Products Ltd., Summit Medical, Surgiform, Mentor Worldwide LLC (Johnson & Johnson), Olympus Corporation, Medtronic, Stryker, Smith & Nephew, Intersect ENT, Inc., and Cook Medical, among others.

Recent Developments

• In May 2023, Index Medical Systems, a healthcare company received regulatory approval from the National Medical Products Administration (NMPA), China to launch over 30 medical tests in the areas of oncology, women’s health, and general wellness screening in China. These will allowIndex to tap into China’s large preventive healthcare screening industry and provide quality healthcare services to more Chinese citizens.
• In July 2022, Bloom Diagnostics, a medtech startup launched its new Bloom Inflammation Test, which measures C-reactive protein (CRP) in the bloodstream to detect inflammation in the body.
• In May 2022, QIAGEN NV, provider of sample and assay technologies for molecular diagnostics launched the QIAstat Dx Rise and advanced panels. QIA stat-Dx Rise and its test cartridges are a closed system for manual sample preparation and processing.
• In January 2022, health screening provider Practo, a mhealth platform launched diabetes screening services across various cities in India. Practo started providing HbA1c, fasting and post-meal blood sugar screening at affordable prices through a network of partner labs. This expanded Practo’s preventive health screening portfolio and enabled more accessibility to diabetes screening services in India
• In June 2021, Grail, a healthcare company introduced the Galleri diagnostic, a single blood test capable of detecting the presence of numerous malignancies. The test is intended to check patients who are already at a high risk of cancer, such as persons over the age of 50.

Nasal Splints Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Nasal Splints Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Nasal Splints Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Nasal Splints Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Nasal Splints Market along with the current trends and future estimations to depict imminent investment pockets. The overall Nasal Splints industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Nasal Splints Market are also analyzed.

Global Nasal Splints Market Segmentation

Market Segmentation

By Product Type

• Malleable Nasal Splints
• Airway Nasal Splints
• Bivalve Nasal Splints
• Septal Nasal Splints
• Others

By Mechanism

• Intranasal Splints
• External NAasal Splints

By Material

• Biodegradable Nasal Splints
• Non-biodegradable Nasal Splints

By Application

• Plastic Surgeries
• Rhinoplasty
• Deviated Septum
• Nasal Fractures
• Others

By End-user

• Hospital & Clinics
• Homecare
• Research Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Network Medical Products Ltd.
• Summit Medical
• Surgiform
• Mentor Worldwide LLC (Johnson & Johnson)
• Olympus Corporation
• Medtronic
• Stryker
• Smith & Nephew
• Intersect ENT, Inc.
• Cook Medical

Airway Clearance Device Market to Reach USD 2.0 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global Airway Clearance Device market is expected to grow rapidly over the next 10 years to reach a value of more than USD 2.0 billion by 2032.

The airway clearance techniques (ACTs) encompasses a variety of methods for eliminating surplus secretions. By lessening airway blockage from secretions filling the airway lumen, re-expanding collapsed lung regions, enhancing gas exchanges, and lowering the inflammatory response, they hope to avoid respiratory tract infections.

Patients with respiratory conditions, including cystic fibrosis, COPD, and asthma, might benefit from using airway clearing devices to help release mucus in their bodies. Thick, glue-like mucus is released from the lungs by the use of airway clearing procedures. Improving lung function and preventing lung infections both benefit from clearing the airways. Devices known as “airway clearance systems” help clear the airways of blockages. These systems can be used to treat bronchiectasis and cystic fibrosis.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS25746/

Airway Clearance Device Market: Key Trends and Drivers

The increasing prevalence of respiratory diseases is one of the major drivers of the Airway Clearance Device market. According to the World Health Organization (WHO), an estimated 235 million people suffer from asthma and 64 million people suffer from COPD, making them the two most common respiratory diseases. The prevalence of these diseases is expected to continue increasing in the coming years, due to the growing air pollution and the changing lifestyle of people. This, in turn, is expected to drive the demand for airway clearance devices, as these devices are used in the management and treatment of these diseases.

The availability of reimbursement policies for airway clearance devices is also expected to drive the growth of the Airway Clearance Device market. Reimbursement policies provide financial support to patients for the purchase and use of these devices. This helps to reduce the financial burden on patients and encourages them to use airway clearance devices for the treatment of their conditions. In the US, Medicare and Medicaid provide reimbursement policies for airway clearance devices.

Airway Clearance Device Market: Restraints and Challenges

One of the major challenges associated with airway clearance devices is the cost. These devices can be expensive, and many patients may not be able to afford them. Additionally, insurance companies may not cover the cost of these devices, making them even more expensive for patients.

Another challenge associated with airway clearance devices is patient compliance. Many patients may find the use of these devices to be uncomfortable or cumbersome, leading them to not use the device as prescribed. Additionally, patients may be confused by the instructions for use and may not use the device correctly. In addition to cost and patient compliance, there are also challenges associated with the efficacy of airway clearance devices. Many studies have shown that these devices may not be effective in clearing the airways of mucus. Additionally, some studies have suggested that the use of these devices may be harmful to the airways, leading to increased airway inflammation and damage.

Airway Clearance Device Market Report Findings

https://www.globalinsightservices.com/reports/airway-clearance-device-market/

The largest and fastest-growing market category is High-Frequency Chest Wall Oscillation (HFCWO)

Based on Device Type, the Airway Clearance Device Market is segmented into Positive Expiratory Pressure (PEP), Oscillatory Positive Expiratory Pressure (OPEP), Mucus Clearance Device, High-Frequency Chest Wall Oscillation (HFCWO), Intrapulmonary Percussive Ventilation (IPV), and Mechanical Cough Assist.  Out of these, High-Frequency Chest Wall Oscillation (HFCWO) segment is experiencing notable growth, driven by advancements in respiratory care technology and an increasing prevalence of respiratory disorders. HFCWO devices, designed to assist in mucus clearance and improve airway function, are gaining prominence across various healthcare settings. The demand is particularly propelled by their effectiveness in managing conditions such as cystic fibrosis, chronic bronchitis, and bronchiectasis. As healthcare providers and patients alike recognize the benefits of HFCWO devices in facilitating airway clearance, the segment is poised for continued expansion, contributing significantly to the overall growth of the Airway Clearance Devices Market.

The largest and fastest-growing market category is Handheld

Based on type, the Airway Clearance Device Market is classified into handheld, and desktop. Among these, the handheld segment has exhibited remarkable growth in 2022 driven by its user-friendly design and enhanced portability. As patients increasingly prioritize convenience in managing respiratory conditions, the demand for handheld airway clearance devices has surged. These devices offer patients greater autonomy in their treatment regimens, enabling them to incorporate airway clearance therapy seamlessly into their daily lives. The compact and lightweight nature of handheld devices not only enhances patient compliance but also fosters a more active and engaged approach to respiratory care. Additionally, technological advancements in handheld devices, such as smart features and connectivity options, further contribute to their popularity. As a result, the handheld segment is expected to continue its upward trajectory, playing a pivotal role in shaping the evolving landscape of airway clearance solutions.

Cystic Fibrosis held the greatest share of this market

Based on Application, the Airway Clearance Device Market is segmented into Cystic Fibrosis, Bronchiectasis, Neuromuscular, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Others. The Airway Clearance Devices Market is witnessing significant growth in the Cystic Fibrosis segment, driven by the escalating prevalence of this genetic disorder and the corresponding rise in demand for advanced therapeutic solutions. Cystic Fibrosis, characterized by thick and sticky mucus in the airways, necessitates effective airway clearance to enhance respiratory function. Airway clearance devices play a pivotal role in managing this condition by assisting in the removal of excess mucus, thereby improving lung function and quality of life for patients. The increasing awareness of the importance of early diagnosis and proactive management of Cystic Fibrosis has spurred the adoption of these devices, fostering robust growth in this specialized segment of the market. In addition,presence of leading players of the airway clearance system market such as Hill Rom, Koninklijke Philips N.V., among others contributes to the market growth. The ongoing advancements in technology, coupled with a focus on patient-centric innovation, are further propelling the development and adoption of airway clearance devices tailored to address the unique challenges posed by Cystic Fibrosis.

The Hospitals and Clinics segment took up the largest portion of this market

On the basis of End User, the Airway Clearance Device Market is classified into Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers, and Others. The Hospitals segment is experiencing robust growth, driven by an increasing demand for advanced respiratory care solutions. As end-users prioritize effective airway clearance therapies for respiratory conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and bronchiectasis, hospitals play a pivotal role in providing comprehensive care. The growing prevalence of respiratory disorders, coupled with the rising aging population, has intensified the need for innovative airway clearance devices within hospital settings. Moreover, the continuous advancements in technology and the introduction of user-friendly, portable devices contribute to the segment’s expansion, enhancing patient compliance and overall healthcare outcomes. With hospitals at the forefront of adopting these cutting-edge technologies, the Airway Clearance Devices Market in the Hospitals segment is poised for sustained growth in the foreseeable future.

In 2022, the Home Health Care setting secured the leading market share and is anticipated to maintain its dominance throughout the forecast period. Focused on facilitating quick recovery and fostering independence, home care emerged as the primary end-user of airway clearance systems in 2018. The segment’s growth is propelled by the increasing demand for rapid, convenient, and cost-effective diagnostic and treatment solutions. According to the Office of the Actuary in the Centers for Medicare & Medicaid Services, home health care spending in the U.S. reached nearly USD 103 billion in 2018 and is projected to surge to USD 173 billion by 2026, underlining the substantial market potential in this sector.

The market for Airway Clearance Device was dominated by North America

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America segment of the Airway Clearance Devices Market has exhibited robust growth driven by several factors. Increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, coupled with a rising aging population, has heightened the demand for advanced airway clearance devices in the region. Moreover, the region’s well-established healthcare infrastructure, technological advancements, and favorable reimbursement policies have further propelled market expansion. Additionally, growing awareness among both healthcare professionals and patients regarding the benefits of early intervention and effective airway clearance therapies has contributed to the increasing adoption of these devices. The North America segment is poised to continue its upward trajectory, with continuous innovation and strategic collaborations within the healthcare sector anticipated to drive further advancements in airway clearance technolog.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS25746/

Competitive Landscape

The key players studied in the report are Thayer Medical (US), Able Healthcare (Australia), Dymedso (Canada), Hill-Rom Holdings, Inc. (US), Koninklijke Philips N.V. (Netherlands), LABINDIA Healthcare Pvt.  (India), Med Systems, Inc. (US), Medtronic (US), Mercury Medical (US), Monaghan Medical Corporation (US), Olympus America Inc. (US), PARI Respiratory Equipment, Inc. (Germany), Rotech Healthcare Inc. (US), SmartVest (Electromed, Inc.) (US), and VORTRAN Medical Technology 1 Inc. (US).

Recent Developments

• In August 2019, Hill-Rom, Inc. acquired Breathe Technologies. This acquisition was a strategic move for the former to enter non-invasive ventilation to provide a heightened growth and higher-margin businesses.
• In August 2019, Electromed, Inc. partnered with two home medical equipment distributors to sell the SmartVest in the U.S. The partnership expects direct sales channel for the airway clearance systems as its primary homecare revenue.
• In April 2018, in the U.S., Sunovion announced the launch of Lonhala Magnair inhalation solution U.S. for the treatment of COPD. This inhalation solution uses eFlow technology developed by PARI Pharma GmbH. Monaghan Medical Corporation also upgraded its existing product by including mask in the AeroChamber brand and renovated it as AeroChamber Plus Flow-Vu.

Airway Clearance Device Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Airway Clearance Device market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Airway Clearance Device market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Airway Clearance Device market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Airway Clearance Device industry.

Global Airway Clearance Device Market Segmentation

By Device Type

• Positive Expiratory Pressure (PEP)
• Oscillatory Positive Expiratory Pressure (OPEP)
• High Frequency Chest Wall Oscillation (HFCWO)
• Intrapulmonary Percussive Ventilation (IPV)
• Mucus Clearance Device
• Mechanical Cough Assist

By Type

• Handheld
• Desktop

By Application

• Cystic Fibrosis
• Neuromuscular
• Bronchiectasis
• Chronic Obstructive Pulmonary Disease (COPD)
• Emphysema
• Others

By End User

• Hospitals and Clinics
• Home Care Settings
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Thayer Medical (US)
• Able Healthcare (Australia)
• Dymedso (Canada)
• Hill-Rom Holdings, Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• LABINDIA Healthcare Pvt. (India)
• Med Systems, Inc. (US)
• Medtronic (US)
• Mercury Medical (US)
• Monaghan Medical Corporation (US)
• Olympus America Inc. (US)
• PARI Respiratory Equipment, Inc. (Germany)
• Rotech Healthcare Inc. (US)
• SmartVest (Electromed, Inc.) (US)
• VORTRAN Medical Technology 1 Inc. (US)

Biosensors Market to Reach USD 51.5 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global Biosensors market is expected to grow rapidly over the next 10 years to reach a value of more than USD 51.5 billion by 2032.

Biosensors is a medical devices designed primarily for the detection or measurement of biological substances like biomolecules or microorganisms. These analytical tools are capable of converting biological responses into electrical signals. Comprising three essential components namely, an analyte-identifying unit generating signals, a signal transducer, and a reader device biosensors have diverse applications in areas such as food and beverages, environmental monitoring, and home care diagnostics. They are also utilized in nanomechanical biosensors. Furthermore, biosensor applications extend to plant biology, where they play a crucial role in studying metabolic processes.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10292/

Biosensors Market: Key Trends and Drivers

The biosensors market is experiencing significant growth driven by a surge in demand for portable biosensors in the Asia Pacific and European regions. The increasing awareness of the importance of rapid and accurate diagnostics, coupled with the growing prevalence of chronic diseases, has fueled the adoption of biosensors. The portability of these devices offers a convenient and efficient solution for point-of-care testing, enabling healthcare professionals to quickly obtain real-time information. Additionally, the rise in health-conscious consumers and the need for continuous monitoring further contribute to the market expansion. As these regions continue to prioritize advancements in healthcare technology, the biosensors market is poised for sustained growth, with portable biosensors playing a pivotal role in shaping the industry growth.

Biosensors Market: Restraints and Challenges

The biosensors market in the medical field faces several constraints that hinder its seamless integration and widespread adoption. One significant challenge is the complexity and variability of biological samples, which can lead to issues such as interference and inaccuracies in sensor readings. Additionally, the high cost of biosensor development and the stringent regulatory requirements for medical devices pose financial and time-related barriers for market players. The need for continuous improvement in sensitivity, specificity, and reproducibility of biosensors further adds to the research and development challenges. Moreover, concerns related to data security and privacy, as biosensors often deal with sensitive health information, contribute to the hesitancy in embracing these technologies on a broader scale. Addressing these constraints requires collaborative efforts from researchers, industry stakeholders, and regulatory bodies to enhance the reliability, affordability, and user-friendliness of biosensors for effective integration into the medical field.

Biosensors Market Report Findings

https://www.globalinsightservices.com/reports/biosensors-market/

The largest and fastest-growing market category is non-wearable biosensor

Based on the type, it is segmented into wearable, and non-wearable. The non-wearable segment in the biosensors market has experienced robust growth driven by technological advancements and increasing applications across diverse industries. Non-wearable biosensors, which include implantable sensors, ingestible sensors, and environmental sensors, have witnessed heightened demand in areas such as healthcare, agriculture, and environmental monitoring. The growing emphasis on continuous, real-time data monitoring and the integration of biosensors into various non-traditional platforms contribute to the segment’s expansion. Additionally, the focus on miniaturization, enhanced sensitivity, and improved communication capabilities further propels the non-wearable biosensors market.

Optical Technology held the greatest share of this market

Based on the technology, it is segmented into thermal, electrochemical, piezoelectric, and optical.  The biosensors market is experiencing a significant growth trajectory, largely propelled by advancements in optical technology. The integration of cutting-edge optical components has revolutionized biosensor performance, offering enhanced sensitivity, real-time monitoring capabilities, and improved detection accuracy. Optical biosensors leverage principles such as surface plasmon resonance and fluorescence, allowing for the rapid and precise analysis of biological samples. This surge in optical segment growth within the biosensors market is attributed to the continuous innovation in optical materials, sensor design, and signal processing techniques. As a result, these biosensors find diverse applications in medical diagnostics, environmental monitoring, and food safety, fostering a promising growth for the integration of optical technologies in the evolving field of biosensing.

The Infectious Disease Testing segment took up the largest portion of this market

Based on the application, it is segmented into Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing, and others. The Infectious Disease Testing segment within the biosensors market is experiencing robust growth, driven by an increasing demand for rapid and accurate diagnostic solutions. Biosensors play a pivotal role in detecting infectious diseases by leveraging their ability to detect specific biomolecules associated with pathogens. The ongoing global focus on public health, coupled with the need for timely disease identification, has propelled the adoption of biosensor-based infectious disease testing. These innovative devices offer advantages such as rapid results, portability, and cost-effectiveness, making them indispensable in point-of-care settings and resource-limited environments. Additionally, advancements in sensor technologies, coupled with a growing emphasis on early detection and monitoring, are likely to sustain the momentum in the Infectious Disease Testing segment of the biosensors market, contributing significantly to its continued expansion.

The Point of Care Testing segment took up the largest portion of this market

Based on the end user, it is segmented into Point of Care Testing, Home Healthcare Diagnostics, and Research Laboratories. The Point of Care Testing (POCT) segment within the biosensors market has experienced substantial growth, driven by the increasing demand for rapid and decentralized diagnostic solutions at the end-user level. These biosensors provide healthcare professionals and patients with real-time and on-site testing capabilities, minimizing the turnaround time for critical medical decisions. The convenience and accessibility of POCT biosensors have proven particularly valuable in scenarios where immediate results are crucial, such as emergency care, remote locations, and home healthcare settings. This growth underscores a paradigm shift towards personalized and patient-centric healthcare, emphasizing the significance of biosensors in delivering timely and accurate diagnostic information at the point of need.

The market for biosensors was dominated by Europe

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American biosensors market is experiencing substantial growth due to the presence of key players and a high incidence of targeted diseases in the region. Projected advancements in technology, including the introduction of miniaturized diagnostic equipment facilitating increased market penetration of Electronic Medical Records (EMR) and providing precise and rapid findings, are anticipated to drive market expansion. Additionally, regulatory frameworks such as the Clean Air Act, Clean Water Act, and National Environmental Policy Act in the U.S. are expected to create growth opportunities for the regional market.

Meanwhile, the Middle East and Africa are poised to exhibit the fastest compound annual growth rate during the forecast period. This growth is attributed to significant unmet medical needs for diseases like cancer, diabetes, and other infectious diseases, coupled with improving healthcare expenditure, rising patient awareness, and increasing demand for home healthcare and point-of-care services. Government initiatives to reduce hospital stays through the development of outpatient care models further contribute to the region’s market growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10292/

Competitive Landscape

The key players studied in the report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Ascensia Diabetes Care Holdings AG, Biosensors International Group, Ltd, Siemens Healthineers AG, Bio-Rad Laboratories, Inc, among others.

Recent Developments

• In January 2023, Intricon Corporation announced the opening of a Bionsensor Center of Excellence (CoE). The center aims to vertically integrate the company’s business to provide biosensors in medical devices.
  In May 2020, Philips has received FDA clearance for its wearable biosensor, the Philips Biosensor BX100, designed to assist in managing confirmed and suspected COVID-19 patients in hospitals. This wireless biosensor, already in use at the OLVG Hospital in the Netherlands, enhances clinical surveillance by detecting vital signs and supporting early intervention for patients in lower acuity care areas. The disposable biosensor, with a 5-day usage cycle, adheres discreetly to the chest, transmitting respiratory and heart rates, along with contextual parameters, without the need for cleaning or charging. The device is part of Philips’ patient deterioration detection solution, providing a scalable and integrated approach to monitoring multiple patients across various rooms.

Biosensors Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Biosensors market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Biosensors market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Biosensors market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Biosensors industry.

Global Biosensors Market Segmentation

By Type

• Wearable biosensors
• Non-wearable biosensors

By Technology

• Electrochemical
• Optical
• Thermal
• Piezoelectric
• Others

By Application

• Blood glucose testing
• Cholesterol testing
• Blood gas analysis
• Pregnancy testing
• Drug discovery
• Infectious disease testing
• Others

By End-User

• Point of care testing
• Home healthcare diagnostics
• Research laboratories
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Siemens Healthineers AG
• Ascensia Diabetes Care Holdings AG
• Bio-Rad Laboratories, Inc
• Biosensors International Group, Ltd
• Dexcom, Inc.
• LifeScan Inc.
• Masimo
• Nova Biomedical
• Pinnacle Technology
• QTL Biosystems
• TE Connectivity Corporation

Resuscitation Devices Market to Reach USD 12.0 billion by 2032, driven by the growth in investment in infrastructure across the globe: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global resuscitation devices market is expected to grow rapidly over the next 10 years to reach a value of more than USD 12.0 billion by 2032.

Resuscitation devices are used to trigger spontaneous breathing by manually ventilating the lungs. When a patient is unconscious or appears to be dead, resuscitation equipment is used to help induce spontaneous breathing or revive the patient’s breath. This is done by filling the patient’s lungs with positive pressure, which keeps them oxygenated. Resuscitation devices include things like ventilators, resuscitation masks, resuscitation suction and mechanical pumps, resuscitation trolleys, resuscitation paediatric spacers, and other tools. Devices used in resuscitation are typically single-patient, disposable, and latex-free.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24634/

Resuscitation Devices Market: Key Trends and Drivers

The resuscitation devices market is being significantly driven by the increasing prevalence of cardiac arrests and respiratory disorders, coupled with a growing awareness of the importance of immediate and effective resuscitation interventions. The rising aging population, along with the escalating incidence of chronic diseases, contributes to the expanding demand for resuscitation devices. Additionally, advancements in technology, such as the development of automated and portable resuscitation devices, are enhancing the accessibility and efficiency of life-saving interventions. As healthcare systems worldwide prioritize emergency preparedness and response, the demand for innovative and user-friendly resuscitation devices is expected to fuel market growth in the foreseeable future.

Resuscitation Devices Market: Restraints and Challenges

The resuscitation devices market faces several challenges and restraints that impact its growth trajectory. Stringent regulatory requirements and compliance standards pose a significant hurdle for market players, demanding rigorous testing and validation processes. Additionally, the high cost associated with advanced resuscitation devices limits their widespread adoption, particularly in resource-constrained healthcare settings. Limited awareness and training among healthcare professionals on the proper use of these devices also hinder their effective deployment, impacting patient outcomes. Moreover, economic constraints in certain regions may impede the market’s expansion, as healthcare facilities may face budgetary constraints in acquiring new and innovative resuscitation technologies. Overall, addressing these market restraints requires a multi-faceted approach involving regulatory streamlining, cost-effective solutions, and comprehensive training programs for healthcare practitioners.

Resuscitation Devices Market Report Findings

https://www.globalinsightservices.com/reports/resuscitation-devices-market/

The airway management devices segment is anticipated to dominate the market during the forecast period

Based on the product, it is segmented into airway management devices, external defibrillators, and connective warming blankets. The external defibrillators segment has witnessed remarkable growth within the Resuscitation Devices Market, driven by advancements in technology, increasing awareness about the importance of prompt defibrillation, and the rising incidence of sudden cardiac arrests (SCA) globally. These devices play a pivotal role in the chain of survival, offering a crucial intervention to restore normal heart rhythm in individuals experiencing life-threatening cardiac arrhythmias. The growing emphasis on public access defibrillation programs, coupled with the integration of user-friendly features in modern external defibrillators, has significantly expanded their applicability beyond traditional healthcare settings. Moreover, the incorporation of innovative technologies, such as automated external defibrillators (AEDs) that guide users through the resuscitation process with clear and simple instructions, has bolstered their widespread adoption in various public spaces, including airports, schools, and sports arenas. The increasing prevalence of cardiovascular diseases and the aging population further underscore the need for effective resuscitation devices, driving sustained demand for external defibrillators. As technological advancements continue to enhance the performance and reliability of these devices, the external defibrillators segment is poised to maintain its growth trajectory, contributing significantly to the overall expansion of the Resuscitation Devices Market in the foreseeable future.

The adult patients segment is anticipated to dominate the market during the forecast period

Based on the type, it is segmented into adult patients, and pediatric patients. The adult segment in the resuscitation devices market has experienced remarkable growth, fueled by a confluence of factors that underscore the increasing emphasis on advanced medical interventions and the rising prevalence of cardiovascular diseases. As the global population ages and the incidence of cardiac emergencies surges, there has been a growing awareness of the critical role played by resuscitation devices in saving lives. Technological advancements in resuscitation equipment tailored specifically for adults, including sophisticated automated external defibrillators (AEDs) and advanced life support (ALS) devices, have contributed significantly to the heightened efficacy and accessibility of emergency medical interventions. Moreover, the integration of innovative features such as real-time feedback mechanisms, user-friendly interfaces, and enhanced connectivity options has further augmented the adoption of adult-focused resuscitation devices across various healthcare settings. Additionally, the escalating demand for comprehensive training programs in cardiopulmonary resuscitation (CPR) and the increasing deployment of these devices in public spaces, workplaces, and healthcare institutions have propelled the adult segment’s growth.

The hospital segment is anticipated to dominate the market during the forecast period

Based on the end user, it is segmented into hospitals, diagnostic centers, and ambulatory surgical centers.
The hospital segment is witnessing robust growth in the Resuscitation Devices Market, driven by an increasing focus on advanced medical interventions and emergency care within healthcare facilities. Hospitals play a pivotal role in managing critical cases, and the rising prevalence of cardiac arrests and other life-threatening conditions necessitates the adoption of state-of-the-art resuscitation devices. The demand for innovative and efficient resuscitation solutions in hospital settings is further fueled by the growing awareness among healthcare professionals about the importance of timely and effective resuscitation measures. Additionally, the continuous technological advancements in resuscitation devices tailored for hospital environments are contributing to the segment’s expansion, ensuring that healthcare providers have access to cutting-edge tools for improving patient outcomes in critical situations.

The North American region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The Resuscitation Devices Market in North America has witnessed significant growth, driven by several factors that underscore the region’s commitment to advancing healthcare infrastructure and emergency medical services. The increasing prevalence of cardiovascular diseases, coupled with a rising awareness of the importance of prompt and effective resuscitation, has fueled the demand for innovative resuscitation devices. Additionally, favorable government initiatives, robust healthcare expenditure, and a well-established emergency response system contribute to the market’s expansion. The region’s emphasis on technological advancements and the adoption of cutting-edge medical devices further propel the growth of the Resuscitation Devices Market in North America, positioning it as a key player in the global healthcare landscape.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24634/

Competitive Landscape

The key players studied in the report are Koninklijke Philips N.V., Medtronic plc, Physio-Control, Drägerwerk AG, Ambu A/S, 3M, GE Healthcare, ZOLL Medical Corporation, Nihon Kohden Corporation, Cardinal Health among others.

Resuscitation Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Resuscitation Devices market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Resuscitation Devices market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Resuscitation Devices market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Resuscitation Devices industry.

Global Resuscitation Devices Market Segmentation

By Product

• Airway Management Devices
• External Defibrillators
• Convective Warming Blankets

By Patient Type

• Adult Patients
• Pediatric Patients

By End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Koninklijke Philips N.V.
• Medtronic plc
• Physio-Control
• Drägerwerk AG
• Ambu A/S
• 3M
• GE Healthcare
• ZOLL Medical Corporation
• Nihon Kohden Corporation
• Cardinal Health

Heart Pump Device Market to Reach USD 15.3 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, November 2023: According to a new research study by Global Insight Services (GIS), the global heart pump device market is expected to grow rapidly over the next 10 years to reach a value of more than USD 15.3 billion by 2032.

Millions of individuals around the world suffer from heart failure, which kills more people annually than all forms of cancer combined. Since there aren’t enough donors for heart transplants, using a reliable mechanical circulatory support system could lengthen patients’ lives and ease their pain. This device can be inserted into either the left or right ventricle of your heart, although the left ventricle is where it is most usually utilized. If a patient suffers heart failure and is not a suitable candidate for a heart transplant, the doctor may recommend having a VAD implanted as a long-term treatment. If you have severe heart failure, the procedure to install these devices—which necessitates open-heart surgery and carries significant risks and complications—can save your life. Following the implants, the patient must visit the doctor to discuss how the device is performing and, if necessary, any issues.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10292/

Heart Pump Device Market: Key Trends and Drivers

Due to the rising prevalence of CVDs and heart failure over the past several years, there has been a major increase in the demand for heart transplants. However, a global shortage issue has emerged due to the lack of sufficient hearts for transplantation to fulfill the current demand. There were roughly 3,980 candidates on the heart transplant waiting list as of March 2018, according to the national database maintained by the Health Resources and Services Administration (US).

Significant variations in the number of donors and patients on waiting lists have been seen, even at the national level. For instance, in Australia, there were around 1,650 people on the waiting list for a heart transplant in 2020, but there were only 463 donors available (Source: Transplant Australia Ltd). According to the Transplant Activity Report 2018/19, since 2010, there have been 134 percent more people active on waiting lists for heart transplants.

Heart Pump Device Market: Restraints and Challenges

For bridge-to-heart transplantation, ventricular support devices, notably left ventricular assist devices (LVADs), are frequently employed. LVADs are thought of as life-saving devices, however they also have a number of difficulties.

By six months after implantation, up to 60% of patients typically experience LVAD-related problems. Nearly 80% of patients had at least one unfavorable incident by two years. Unexpected readmissions to the hospital are frequent. Patients are observed to be readmitted on average 2.2 times throughout the course of their median follow-up period of 11 months.

Heart Pump Device Market Report Findings

https://www.globalinsightservices.com/reports/heart-pump-device-market/

The largest and fastest-growing market category is ventricular assist devices

Based on the product, it is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial hearts. The Ventricular Assist Devices (VADs) segment in the Heart Pump Device Market has witnessed remarkable growth driven by advancements in technology and a rising prevalence of heart failure. These innovative devices play a pivotal role in supporting patients with weakened hearts by assisting the pumping function, thereby improving overall cardiac output. The increasing adoption of VADs can be attributed to their effectiveness in enhancing patient outcomes and quality of life. Additionally, ongoing research and development efforts have led to the introduction of more compact and durable devices, further expanding the potential patient population. As healthcare providers and patients increasingly recognize the benefits of ventricular assist devices, the market is poised for continued growth, with the potential to transform the landscape of heart failure treatment.

Implanted heart pump devices held the greatest share of this market

Based on the therapy, it is segmented into implanted heart pump devices and extracorporeal heart pump devices. The implanted heart pump devices segment in the heart pump device market has witnessed remarkable growth  due to advancements in medical technology and an increasing prevalence of cardiovascular diseases. These devices, such as ventricular assist devices (VADs) and total artificial heart (TAH), play a critical role in supporting heart function and improving the quality of life for patients with advanced heart failure. The rising awareness among healthcare professionals about the efficacy of implanted heart pump devices, coupled with their ability to provide both short-term and long-term mechanical circulatory support, is driving the demand for these devices. Moreover, ongoing research and development efforts are contributing to the enhancement of device design, durability, and overall performance, further fueling the growth of this segment in the heart pump device market.

The BTT segment took up the largest portion of this market

Based on the therapy, it is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and other therapy. The Bridge-to-Transplant (BTT) therapy, has exhibited substantial growth in recent years. As advancements in medical technology continue to unfold, the demand for these devices has surged, driven by an increasing prevalence of heart failure and a growing awareness of the therapeutic benefits offered by mechanical circulatory support. The Bridge-to-Transplant segment, in particular, has witnessed a notable uptick as these devices serve as a crucial lifeline for patients awaiting heart transplantation. The technology’s ability to provide temporary circulatory support while patients await a suitable donor heart positions it as a critical component in the management of end-stage heart failure. This growth is further fueled by ongoing research and development efforts, enhancing the efficacy and safety of these devices, thereby expanding their application and market reach. As the healthcare industry continues to prioritize innovative solutions for cardiovascular diseases, the Heart Pump Device Market’s Bridge-to-Transplant segment is poised for sustained expansion in the foreseeable future.

The market for heart pump devices was dominated by Europe

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Heart Pump Device Market is experiencing robust segment growth driven by advancements in technology, increasing prevalence of cardiovascular diseases, and a rising aging population. Continuous innovation in heart pump technologies, such as the development of more efficient and durable devices, is fostering market expansion. Moreover, a growing awareness of heart failure and the benefits of mechanical circulatory support devices among both healthcare professionals and patients is propelling the demand for these devices. Additionally, favorable reimbursement policies and a well-established healthcare infrastructure in North America further contribute to the positive growth trajectory of the Heart Pump Device Market in the region.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10292/

Competitive Landscape

The key players studied in the report are Abbott Laboratories, Abiomed, Medtronic, Teleflex Incorporated, SynCardia Systems, Fresenius Medical Care AG & Co. KGaA, Getinge, CardiacAssist, Inc., Berlin Heart, Jarvik Heart, Inc., CARMAT, SENKO MEDICAL INSTRUMENT Mfg. CO., LTD., Angiodroid, and CardioDyme among others.

Recent Developments

• February 2021, Carmat received FDA approval to use the new version of its artificial heart in the US early feasibility study.
• December 2020, Abbott received FDA approval for the updated labeling for the HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.
• December 2020, Carmat received the CE mark for its total artificial heart.
• March 2020, SynCardia Systems received FDA approval for the 50cc temporary total artificial heart.
• In December 2022, Abbott has launched new minimally invasive device for treating heart valve diseases in India. The newly launched Navitor TAVI system is the latest addition to the company’s heart trans-catheter portfolio, which offers less invasive options for treating heart diseases.
• In March 2020, Abbott received breakthrough device designation from the FDA (Food and Drug Administration) for its Fully Implantable Left Ventricular Assist System (FILVAS).
• In February 2017, Boston Scientific launched its new “RESONATE” cardiac resynchronization therapy defibrillator (CRT-D) system in Europe. A newly launched device with SmartCRT technology has received the CE mark and is now available in Europe for heart failure patients.

Heart Pump Device Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Heart Pump Device market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Heart Pump Device market potential from 2021 to 2031 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Heart Pump Device market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Heart Pump Device industry.

Global Heart Pump Device Market Segmentation

By Product

• Ventricular Assist Devices
• Intra-Aortic Balloon Pumps
• Total Artificial Hearts

By Type

• Implanted Heart Pump Device
• Extracorporeal Heart Pump Device

By Therapy

• Bridge-to-Transplant (BTT)
• Bridge-to-Candidacy (BTC)
• Destination Therapy (DT)
• Other Therapies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Abbott Laboratories
• Abiomed
• Medtronic
• Teleflex Incorporated
• SynCardia Systems
• Fresenius Medical Care AG & Co. KGaA
• Getinge
• CardiacAssist, Inc.
• Berlin Heart
• Jarvik Heart, Inc.
• CARMAT
• SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
• Angiodroid
• CardioDyme

New York, October 2023: According to a new research study by Global Insight Services (GIS), the Intrauterine Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 4.4 billion by 2032.

An Intrauterine device is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, altering the cervical mucus and making it difficult for sperm to reach and survive an egg. It can also prevent a fertilized egg from implanting itself. IUDs are widely preferred over other methods of contraception because they are compact, safe, and cost-effective, and they have no hormonal side effects such as acne, headaches, or breast tenderness. It is currently available in various types that can last for a period of 5 to 10 years.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS24311/

Global Intrauterine DevicesMarket: Market Drivers and Trends

The rise in awareness over the availability of the devices through campaigns is the primary driver of the industry’s growth. One of the key factors influencing global demand for IUDs are initiatives taken by various countries’ health agencies, in collaboration with non-profit organizations (NPOs), to raise awareness about family planning, the benefits of birth control measures, and health-related issues caused by unplanned pregnancies are promoting market growth. Furthermore, because IUDs have a very low risk of ectopic pregnancy, they are gaining popularity among nulliparous women and adolescents who have never given birth and are at a higher risk for negative birth outcomes such as breast and reproductive cancers.

Furthermore, the rise in unplanned and unwanted pregnancies, which has become one of the world’s major concerns. For Instance, according to the World Health Organization (WHO) and the International Federation of Medical Students’ Associations’ 2018 report, approximately 22 million unsafe abortions are performed globally each year, resulting in the deaths of an estimated 47,000 women, Aside from that, the development of advanced product variants with fewer side effects, such as postpartum, slimmer, and reusable IUDs, is expected to offer lucrative growth opportunities to industry investors in the coming years. These factors are expected to drive the growth of the global Intrauterine Devices Market.

Global Intrauterine Devices Market: Market Restraints and Challenges

The factors that are impeding the market lack of proper knowledge on use of devices, pelvic inflammatory infection, infertility issues, and limited access for conception are limiting the market growth. Additionally, fewer patients experience side effects such as cramps, irregular periods, heavy periods with stronger cramping and others are hindering the global Intrauterine Devices Market growth and further restrict the growth of the market.

Global Intrauterine Devices Market Report Findings

https://www.globalinsightservices.com/reports/intrauterine-devices-market/

The hormonal segment is likely to hold the major share of the market in 2022

Based on type, it is bifurcated into copper, and hormonal. The hormonal segment is expected to be the largest segment in the Intrauterine Devices Market in 2022.One of the primary drivers is the increasing preference among women for long-acting reversible contraceptive methods that offer both high efficacy and convenience. Hormonal IUDs, characterized by their ability to release progestin, not only provide effective birth control but also offer benefits such as reduced menstrual bleeding and alleviation of associated symptoms like dysmenorrhea. Moreover, the ease of insertion and the extended duration of effectiveness, which can range from three to five years depending on the product, make hormonal IUDs an attractive choice for women seeking reliable and hassle-free contraceptive options. This combination of superior contraceptive efficacy, menstrual management, and user convenience has positioned hormonal IUDs as a leading choice in the rapidly growing Intrauterine Devices Market.

Furthermore, because of their numerous health benefits and improved patient outcomes, these hormonal IUDs are recommended by healthcare professionals. Hormonal IUDs are considered extremely safe due to their non-contraceptive benefits and can be used by patients suffering from heavy menstrual bleeding, endometriosis, anaemia, fibroids, and other conditions. Hormonal IUDs prevent pregnancies by thickening the mucus in the cervix and thinned the uterine lining, which partially suppresses ovulation. As a result, the numerous advantages and health benefits provided by hormonal IUDs are expected to drive demand for hormonal IUDs.

The 25-34 segment is likely to hold the major share of the market in 2022

Based on age group, the market is bifurcated into 15-24, 25-34, 35-44, and above 44. The 25-34 segment dominated the market in 2022, The dominance of the 25-34 age group in the Intrauterine Devices (IUD) market in 2022 can be attributed to several key drivers. This age group often represents individuals who are in their prime childbearing years and may have a heightened awareness of the need for effective contraception methods to plan their families. Moreover, there has been a notable increase in the overall awareness and education surrounding IUDs as a reliable and long-acting contraceptive option, making them a preferred choice for those seeking to delay or control their family planning. Furthermore, concerns about adolescent sexual activity have contributed to this trend, as early sexual engagement can lead to premarital and unplanned pregnancies, a risk that this age group aims to mitigate through the use of IUDs. The desire for greater reproductive autonomy and the ability to balance personal and professional aspirations also drive the adoption of IUDs among those aged 25-34, as they seek to avoid the potential disruptions that can arise from unplanned pregnancies, including early school termination or abortion. These factors collectively make IUDs a favored choice among individuals in the 25-34 age group for their contraceptive needs.

The hospitals segment is likely to hold the major share of the market in 2022

Based on end-user, the Intrauterine Devices Market is segmented into hospitals, clinics, community healthcare centers and others. The hospital segment dominated the market in 2022. This is attributed to the increasing number of patient visits for family planning, which serves as a significant driver for market growth during the forecast period. Hospitals are often the primary healthcare providers for women seeking contraception and family planning services, as they offer a comprehensive range of reproductive health services and have well-established gynecological departments. This makes hospitals a convenient and trusted choice for women seeking IUD insertion, as they can receive expert guidance, counseling, and medical care, thereby contributing to the higher utilization of IUDs in a hospital setting. Moreover, the hospital setting ensures adherence to stringent medical protocols, ensuring that the insertion and management of IUDs are performed with precision, reducing the risk of complications and promoting patient safety and satisfaction. This, coupled with the increasing awareness and acceptance of IUDs as a reliable and long-acting contraceptive method, will strengthen the hospital as well as Intrauterine Devices Market growth during the forecast period.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is dominating in the Intrauterine Devices Market. First and foremost, the region benefits from a robust healthcare infrastructure, coupled with advanced research and development capabilities, fostering the innovation and commercialization of cutting-edge IUD technologies. Moreover, a high level of awareness and acceptance of contraceptives among the populace, supported by comprehensive sex education and well-established healthcare policies, has significantly propelled the demand for IUDs.

Additionally, the presence of key market players and a favorable regulatory environment, characterized by stringent quality standards and streamlined approval processes, further bolsters the region’s leadership in the global IUD market, facilitating the rapid adoption and distribution of these devices across the continent.  Moreover, high demand for both copper and hormone-based devicesi. For instance, in the United States, around 62 million women use contraception, with approximately 43 million at risk of unintended pregnancy. Additionally, government initiatives promoting birth control awareness and affordability further fuel market growth.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS24311/

Competitive Landscape

The key players studied in the global Intrauterine Devices Market are Abviee Inc. (US), CooperSurgical Inc. (US), DKT International (US), Eurogine, S.L. (Spain), HLL Lifecare (India), Lupin Pharmaceuticals (India), Mona Lisa NV (Germany), Pregna International Limited (India), Prosan International BV (Netherlands), and Viatris Inc (US) among others.

Global Intrauterine Devices Market: Recent Developments

• In June 2021, Sebela Pharmaceuticals Inc. is conducting a phase III clinical trial with PRA Health Sciences to evaluate LevoCept, a long-acting reversible intrauterine system, for contraceptive efficacy, safety, and tolerability. The trial is scheduled to conclude in June 2027.
• In February 2020, Agile Therapeutics, Inc. received FDA approval for Twirla transdermal system, which is indicated as a method of contraception for use in women of reproductive potential with a BMI of 30 kg/m2 who require a combined hormonal contraceptive.
• In September 2019, Kyleena, a Bayer’s intrauterine device, has been approved by the US Food and Drug Administration. This device is extremely effective at preventing pregnancy and has few side effects.

Global Intrauterine Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Intrauterine Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future global Intrauterine Devices Market potential from 2022 to 2032 in terms of revenue ($ Million), and Volume (Units).
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the global Intrauterine Devices Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Intrauterine Devices industry.

Global Intrauterine Devices Market Segmentation

By Type

• Copper
• Hormonal

By Age Group

• 15-24
• 25-34
• 35-44
• Above 44

By End-User

• Hospitals
• Clinics
• Community Healthcare Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • Middle East
  • Africa

Key Players

• Abviee Inc. (US)
• CooperSurgical Inc. (US)
• DKT International (US)
• Eurogine, S.L. (Spain)
• HLL Lifecare (India)
• Lupin Pharmaceuticals (India)
• Mona Lisa NV (Germany)
• Pregna International Limited (India)
• Prosan International BV (Netherlands)
• Viatris Inc (US)

New York, October 2023: According to a new research study by Global Insight Services (GIS), the Medical Suction Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 1.5 billion by 2032.

A medical suction device is a piece of medical equipment that is used to remove bodily fluids, secretions, or pollutants from a patient’s body. It works by applying negative pressure to a collecting container, which attracts fluids or pollutants into it. Suction devices are frequently used in emergency and clinical settings such as hospitals, ambulances, and home care settings to assist patients who are unable to remove secretions on their own.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/inquiry-before-buying/GIS25885

Global Medical Suction Devices Market: Market Drivers and Trends

One of the primary reasons driving market expansion is the rising frequency of chronic respiratory disorders. According to the WHO 2019 study, over 65 million people suffer from moderate to severe COPD, and over 3.2 million people die from this condition each year. According to the same source, asthma is the most frequent chronic condition among children, with approximately 262 million people suffering from it in 2019. As a result, suctioning a patient with asthma or COPD requires the use of a medical suction apparatus. Because COPD and asthma induce a rise in airway secretions, which can obstruct the airway. As a result, demand for medical suction devices is expected to rise throughout the forecast period.

Additionally, the medical suction equipment market is expanding as the elderly population grows. According to the United Nations Population Division’s Global Population Prospects 2022 Revision, which was issued in June 2022, there will be 729.4 million individuals aged 65 and over in the globe in 2022. This was a 1.6% rise over 2021 and a 10.6% increase over 2010. According to the estimate, the number of individuals aged 65 and over will continue to rise, reaching 1.5 billion by 2030 and 2.1 billion by 2050. As the aging population grows and becomes more aware of chronic respiratory problems, the market is likely to expand. The aging population is driving the need for compact portable suction devices that may be employed in home care settings. These drivers are likely to propel market expansion.

Global Medical Suction Devices Market: Market Restraints and Challenges

The rigorous development process, as well as the related government restrictions and clearances for medical equipment manufacture impede the market. However, inadequate reimbursement coverage for medical suction devices used in-home care is expected to limit market growth in the future years.

Global Medical Suction Devices Market Report Findings

https://www.globalinsightservices.com/reports/medical-suction-devices-market/

The portable suction devices segment is likely to hold the major share of the market in 2022

By product type, the market is divided into portable suction devices, wall-mounted suction devices, high-volume suction devices, and handheld suction devices. The portable suction devices is expected to dominate the market during the forecast period.

The surgical suction segment is likely to hold the major share of the market in 2022

By application, the market is classified into surgical suction, airway and respiratory suction, pleural and thoracic drainage, gastric and digestive tract suction, wound drainage, and others. The surgical suction segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period.

The biotechnology companies segment is likely to hold the major share of the market in 2022

Based on end-user, the Medical Suction Devices Market is segmented into hospitals and clinics, ambulatory surgical centers, home healthcare, and emergency medical services (EMS). In 2022, the hospitals and clinics segment dominated the market in terms of revenue and is expected to be the same during the upcoming years.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Medical Suction Devices Market value followed by Asia Pacific. The presence of several major players, such as Allied Healthcare Products, Inc., Amsino International, Inc., Drive DeVilbiss Healthcare, GENSTAR TECHNOLOGIES, Labconco Corporation, and Medela AG, as well as advancements in medical suction device manufacturing technology in the region, drive market growth. This is mostly due to an increase in the number of endoscopic procedures that need a medical suction device, an increase in the number of operations performed, an increase in government support for medical suction device development, and a considerable increase in capital income in industrialized nations. Furthermore, the presence of advanced reimbursement structures aimed at lowering spending levels propels the expansion of the medical suction devices sector. As a result, such factors drive market expansion. Furthermore, the United States is likely to contribute a significant part of the regional market and fuel the growth of the medical suction devices market during the forecast period. The development of a well-established healthcare infrastructure, strong buying power, and an increase in medical suction device adoption rate are projected to boost market expansion.

Have a question for our analyst

https://www.globalinsightservices.com/request-sample/GIS25885

Competitive Landscape

The key players studied in the global Medical Suction Devices Market are Medtronic (USA), Stryker Corporation (USA), Aspirus Mediquip (USA), Laerdal Medical (Norway), Atmos Medizintechnik GmbH & Co. KG (Germany), Allied Healthcare Products, Inc. (USA), Precision Medical, Inc. (USA), Weinmann Emergency Medical Technology (Germany), Allied Healthcares Products Inc. (USA), and Olympus Corporation (Japan).

Global Medical Suction Devices Market: Recent Developments

• In July 2021, Amsino International, Inc. (US) opened a new production and distribution center in Illinois, the United States, to expand its manufacturing capacity and generate additional employment.
• In December 2020, Lympus Corporation (Japan) to expand the company’s respiratory product line and client base bought Veran Medical Technologies, Inc. (US).
• In May 2020, Medela AG (Switzerland) has developed a new production line in the United States and tripled production in Switzerland for its Critical Portable Suction Systems, which are used to assist COVID-19-infected patients who require ventilator support.

Global Medical Suction Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Medical Suction Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future global Medical Suction Devices Market potential from 2022 to 2032 in terms of revenue ($ Million), and Volume (Units).
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the global Medical Suction Devices Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Medical Suction Devices Market industry.

Global Medical Suction Devices Market Segmentation

By Product Type

• Portable Suction Devices
• Wall-Mounted Suction Devices
• High-Volume Suction Devices
• Handheld Suction Devices

By Application

• Surgical Suction
• Airway and Respiratory Suction
• Pleural and Thoracic Drainage
• Gastric and Digestive Tract Suction
• Wound Drainage
• Others

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Healthcare
• Emergency Medical Services (EMS)

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • Middle East
  • Africa

Key Players

• Medtronic (USA)
• Stryker Corporation (USA)
• Aspirus Mediquip (USA)
• Laerdal Medical (Norway)
• Atmos Medizintechnik GmbH & Co. KG (Germany)
• Allied Healthcare Products, Inc. (USA)
• Precision Medical, Inc. (USA)
• Weinmann Emergency Medical Technology (Germany)
• Allied Healthcares Products Inc. (USA)
• Olympus Corporation (Japan).

New York, October 2023: According to a new research study by Global Insight Services (GIS), the Medical Device Analytical Testing Outsourcing Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 12.8 billion by 2032.

Outsourcing analytical testing for medical devices aids in monitoring and maintaining the performance, accuracy, and precision of the equipment. As part of the quality control process, a medical device manufacturer outsources medical device testing. This testing comprises a thorough examination, inspection, and evaluation of the item to ensure that it functions effectively and is appropriate for practical use. Physical testing, bioburden testing, extractable & leachable testing, and other types of analytical testing for medical devices are utilized for cardiovascular devices, orthopedic devices, and many other types of equipment.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS25883

Global Medical Device Analytical Testing Outsourcing Market: Market Drivers and Trends

The increased use of acquisition methods by various important companies across the world to develop their businesses is expected to favorably impact market growth. Pace Analytical Services, a branch of Pace Science and Technology Company, for example, approved the acquisition of Specified Testing Laboratories, LLC in March 2022. Pace clients in New York and nearby states now have more options for analytical and environmental testing services as a result of this transaction.

Additionally, the need for medical device analytical testing outsourcing is not only seen in developed nations, but also in developing countries such as China, Brazil, and India, which fuels the market’s growth. The accessibility of professional outsourcing organizations that satisfy regulatory standards, as well as the rise in demand for cosmetic operations, which necessitate the use of medical devices, are the drivers driving market expansion.. These drivers are likely to propel market expansion.

Global Medical Device Analytical Testing Outsourcing Market: Market Restraints and Challenges

However, outsourcing lowers the costs of such procedures, which is expected to boost market growth. The Medical Device Analytical Testing Outsourcing Market has its downsides. The main disadvantage of medical device analytical testing outsourcing is that it takes place in third-world nations, which may still be price-sensitive for medical device analytical testing, resulting in a major hindrance to the medical device analytical testing outsourcing sector.

Global Medical Device Analytical Testing Outsourcing Market Report Findings

https://www.globalinsightservices.com/reports/medical-device-analytical-testing-outsourcing-market/

The class 1 devices segment is likely to hold the major share of the market in 2022

By type of medical device, the market is divided into class I devices, class II devices, class III devices. The class 1 devices is expected to dominate the market during the forecast period.

The CRO segment is likely to hold the major share of the market in 2022

By service providers, the market is classified into contract research organizations (CROs), testing laboratories, academic and research institutions. The CRO segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period.

The biotechnology companies segment is likely to hold the major share of the market in 2022

Based on end-user, the Medical Device Analytical Testing Outsourcing Market is segmented into medical device manufacturers, biotechnology companies, pharmaceutical companies, government regulatory agencies, and others (e.g., hospitals and clinics). In 2022, the biotech companies segment dominated the market in terms of revenue and is expected to be the same during the upcoming years.

The Asia Pacific region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific has the biggest market share in terms of Medical Device Analytical Testing Outsourcing Market value followed by North America. The presence of many key competitors in the area, including Pace Analytical, North American Science Associates, LLC, Charles River Laboratories International, Inc., and The Smithers Group Inc., as well as advancements in technology for medical device analytical testing, support the market’s growth. Furthermore, well-established healthcare infrastructure, high purchasing power for medical devices, and an increase in the development of modern technology devices such as surgical microscopes, surgical robots, neurological devices, and ophthalmic surgical devices are required for analytical testing, which is expected to drive market growth. Furthermore, the main competitors in this region’s acquisitions and integration drive market expansion. Pace Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and branch of Pace Science and Technology Company announced the acquisition of Meridian BioGroup (Meridian) in August 2022. This purchase will assist them in developing and maintaining regulatory-compliant biopharmaceutical operations and quality management systems.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS25883

Competitive Landscape

The key players studied in the global Medical Device Analytical Testing Outsourcing Market are Eurofins Scientific (Luxembourg), Nelson Laboratories (United States), Toxikon Corporation (United States), SGS SA (Switzerland), WuXi AppTec (China), Charles River Laboratories (United States), Intertek Group (United Kingdom), Pace Analytical Services (United States), Avomeen Analytical Services (United States), and North American Science Associates, Inc. (NAMSA) (United States).

Global Medical Device Analytical Testing Outsourcing Market: Recent Developments

• In December 2022, Pace Analytical Services, a division of Pace Science and Technology Company that specializes in in-lab, mobile, and emergency onsite specialty-contaminant and regulatory testing and analysis services, has announced the acquisition of Special Pathogens Laboratory.
• In August 2022, Pace Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and branch of Pace Science and Technology Company, have bought Meridian BioGroup (Meridian). This purchase will assist them in developing and maintaining regulatory-compliant biopharmaceutical operations and quality management systems.
• In May 2022, Intertek’s contract with the Philippines Bureau of Customs for the Bulk and Break Bulk Cargo Clearance Enhancement Programme has been renewed.
• In May 2022, Intertek announced the creation of “Intertek Hydrogen,” which will help the hydrogen sector ensure the commercialization of groundbreaking technologies in the future.
• In March 2022, Pace Analytical Services, a part of Pace Science and Technology Company, has acquired Specified Testing Laboratories, LLC. Pace clients in New York and nearby states now, have more options for analytical and environmental testing services because of this transaction.

Global Medical Device Analytical Testing Outsourcing Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Medical Device Analytical Testing Outsourcing Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future global Medical Device Analytical Testing Outsourcing Market potential from 2022 to 2032 in terms of revenue ($ Million), and Volume (Units).
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the global Medical Device Analytical Testing Outsourcing Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Medical Device Analytical Testing Outsourcing Market industry.

Global Medical Device Analytical Testing Outsourcing Market Segmentation

By Animal Type

• Class 1 Devices
• Class 2 Devices
• Class 3 Devices

By Service Providers

• CROs
• Testing Laboratories
• Academic and Research Institutes

By End-User

• Medical Device Manufacturers
• Biotechnology Companies
• Pharmaceutical Companies
• Government Regulatory Agencies
• Others (e.g., Hospitals and Clinics)

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • Middle East
  • Africa

Key Players

• Eurofins Scientific (Luxembourg)
• Nelson Laboratories (United States)
• Toxikon Corporation (United States)
• SGS SA (Switzerland)
• WuXi AppTec (China)
• Charles River Laboratories (United States)
• Intertek Group (United Kingdom)
• Pace Analytical Services (United States)
• Avomeen Analytical Services (United States)
• North American Science Associates, Inc. (NAMSA) (United States)

New York, September 2023: According to a new research study by Global Insight Services (GIS), the Wound Closure Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 17.7 billion by 2032.

Wound closure devices are those that help to close a wound. It works by drawing the wound edges and tissues jointly to aid in healing. There are several products on the market that aid with wound closure. Strips, mechanical wound closure devices, adhesives, staples, and sutures are some of the most common wound closure devices. These devices aid in the strengthening of injured tissue as well as the reduction of tissue damage. Furthermore, they aid in reducing the chance or hazard of severe scarring and infection.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS25736/

Wound Closure Devices Market: Market Drivers and Trends

The rising frequency of chronic wounds that consist of diabetic foot ulcers, venous leg ulcers, and pressure ulcers is expected to drive demand for wound closure devices. According to B. Braun Melsungen AG research, diabetic foot ulcers afflict between 2.0% to 10.0% of patients with diabetes. Furthermore, according to the American College of Physicians, the global yearly incidence of diabetic foot ulcers in 2017 was roughly 6.3%, and the lifetime risk of foot ulcers in diabetic individuals ranged from 19.0% to 34.0%. According to the National Centre for Biotechnology Information (NCBI), the prevalence rate of diabetic foot ulcers in North America in 2017 reached 13.0% (highest), which was 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, and 13.0% in the United States. Chronic wounds are treated using wound closure devices which include sutures, staples, and mechanical wound closure systems.

Furthermore, there has been an increase in the total number of surgical operations performed throughout the world in recent years. One of the primary causes driving an increase in the number of procedures is the rising prevalence of chronic conditions such as cancer, diabetes, and autoimmune disorders. Infectious and non communicable illnesses have become more common in recent decades. These drivers are likely to propel market expansion.

Wound Closure Devices Market: Market Restraints and Challenges

The high rivalry that leads to pricing pressure is one of the major hurdles to the worldwide wound closure devices market’s growth. The market is accessible to small businesses for producing wound closure goods that include sutures, hemostats, surgical staples, and tissue sealants, despite the fact that few big manufacturers dominate a few product groups. When opposed to large, branded enterprises with names like Ethicon and Covidien (Medtronic), local competitors produce and distribute these items at much-reduced costs. Devices that are accessible at a low cost in developing nations are projected to increase faster. However, sophisticated items of greater quality are preferred by industrialized countries. Hence, these factors are expected to restrain growth of the market during the forecast period.

Wound Closure Devices Market Report Findings

https://www.globalinsightservices.com/reports/wound-closure-devices-market/

The acute segment is likely to hold the major share of the market in 2022

Based on wound type, the Wound Closure Devices Market is segmented into chronic and acute. The acute segment is expected to dominate the market during the forecast period. This is due to an increase in the number of operations and burn cases worldwide. According to WHO, around USD 26.00 million are allocated each year in South Africa for the treatment of burns caused by kerosene cooking burner events. Such severe injuries need prompt treatment using cutting-edge medical technology. Poverty, a lack of basic safety precautions, the use of paraffin for non-electric home appliances, alcohol misuse, and smoking are the key causes of a large number of burn cases.

The sutures segment is likely to hold the major share of the market in 2022

By product, the market is classified into adhesives, staples, sutures, strips, sealants, and mechanical wound closure devices. The sutures segment is further segmented into absorbable, and non-absorbable. Also, the strips segment is further bifurcated into sterile, and non-sterile. Similarly, sealants is sub-segmented into synthetic, non-synthetic, and collgen-based. The sutures segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. attributable to the increased frequency of incidents around the globe. Sutures are needles with thread connected to them that come in a range of forms, sizes, and thread materials. Sutures are further classified as absorbable or non-absorbable. The absorbable suture market is expected to develop the quickest throughout the forecast period because they are far more convenient and easier to use than non-absorbable sutures.

The hospital segment is likely to hold the major share of the market in 2022

Based on end-user, the Wound Closure Devices Market is segmented into hospitals, hospitals, clinics, trauma centers, and others. In 2022, the hospital segment dominated the market in terms of revenue and is expected to be the same during the upcoming years. This is attributed to the increased number of operations and increasing occurrences of road accidents. According to WHO, nearly 1.35 million people die each year in traffic accidents, which cost most nations nearly 3.0% of their GDP.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Wound Closure Devices Market value followed by Asia Pacific. This is because of the presence of key actors in the region, as well as the increased frequency of chronic wounds. Furthermore, the growing number of patients having procedures and growing knowledge about surgeries that are minimally invasive are driving regional market expansion. 3M, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Medtronic, and Baxter are key participants in the North American market. These firms are making investments in R&D to create medical gadgets that help speed up wound closure.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS25736/

Competitive Landscape

The key players studied in the Wound Closure Devices Market are 3M, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Medtronic, Baxter, Integra LifeSciences Corporation, Smith & Nephew, Mölnlycke Health Care AB, Medline Industries, Inc., and AVITA Medical among others.

Wound Closure Devices Market: Recent Developments

• In June 2021, Ethicon Plus sutures were the first to be approved for use in the NHS by NICE Medical Technologies Guidance as they have been demonstrated to lower the possibility of surgical site infections (SSIs) by over 30%.
• In November 2020, Trubarb, a knotless tissue closure device launched by Healthium, is an efficacious triangular end stopper that removes the need for knotting as compared to a normal suture.
• In March 2020, LiquiBand Plus, developed by Advanced Medical Solutions Limited, was approved by the FDA to heal readily approximated skin margins of wounds after surgical incisions.
• In February 2020, Wego-Stainless Steel suture was approved by the FDA for applications such as abdominal wound closure, hernia repair, and sternal closure by Foosin Medical Supplies Inc., Ltd.

Wound Closure Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Wound Closure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future global Wound Closure Devices Market potential from 2022 to 2032 in terms of revenue ($ Million) and Volume (Units).
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the global Wound Closure Devices Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Wound Closure Devices Market industry.

Wound Closure Devices Market Segmentation

By Wound Type

• Chronic
• Acute

By Product

• Adhesives
• Staples
• Sutures
  • Absorbable
  • Non-Absorbable
• Strips
  • Sterile
  • Non-Sterile
• Sealants
  • Synthetic
  • Non-synthetic
  • Collagen-based
• Mechanical Wound Closure Devices

By End-User

• Hospital
• Clinics
• Trauma centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• 3M
• Johnson & Johnson Services, Inc.
• B. Braun Melsungen AG
• Medtronic
• Baxter
• Integra LifeSciences Corporation
• Smith & Nephew
• Mölnlycke Health Care AB
• Medline Industries, Inc.
• AVITA Medical

New York, September 2023: According to a new research study by Global Insight Services (GIS), the Meniscus Repair System Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 1.1 billion by 2032.

A meniscus rupture is a frequent injury to the meniscus, which is a component of the knee. In the knee joint, the menisci consist of two crescent-shaped pads of thick, rubbery shock-absorbing cartilage. The Meniscal Repair System is designed for use during meniscal repair and allograft transplant surgeries. An outpatient surgical approach to replace damaged knee cartilage is arthroscopic meniscus repair. A torn meniscus is treated using a number of minimally invasive procedures, and recovery requires postoperative protection. These systems are generally comprised of a collection of specialized equipment and gadgets utilized during arthroscopic surgery for fixing the meniscus. Meniscus repair systems of many varieties are available on the market, including all-inside meniscal repair systems, outside-in meniscal repair systems, and others.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS25735/

Meniscus Repair System Market: Market Drivers and Trends

Increased technical progress and research & development activities by market-leading players in the industry of meniscus repair implants and systems drive market expansion. In recent years, advancements in minimally invasive arthroscopy procedures have become the norm for meniscus surgery, since they allow for smaller incisions and quicker recovery periods. For example, Arthrex Inc.’s Meniscal Root Avulsions technology allows for less invasive RetroConstruction repair, which helps to preserve bone while completing meniscal root repair. In addition, biological implants produced from animal tissue, synthetic materials are being utilized to fix, or substitute damaged meniscus tissue. These drivers are likely to propel market expansion.

Meniscus Repair System Market: Market Restraints and Challenges

The high cost of meniscus repair operations, on the other hand, is expected to limit the widespread use of meniscus repair systems throughout the projection period. Meniscus repair procedures are expensive because they need specialized medical equipment and technology, such as robotic-aided surgery systems and arthroscopy tools. Furthermore, meniscus repair operations are sophisticated and need the expertise of a professional surgeon, whose services might be pricey. As a result, the high surgical costs are unaffordable for a small number of patients, limiting market expansion. For example, the cost of meniscal tear surgery ranges between $7,400 and $9,000, depending on the patient’s age. Furthermore, meniscus repair devices, surgery, and other associated costs add to the entire cost of surgery. As a result, the high cost of meniscus repair procedures stifles market growth. Hence, these factors are expected to restrain growth of the market during the forecast period.

Meniscus Repair System Market Report Findings

https://www.globalinsightservices.com/reports/meniscus-repair-system-market/

The all-inside meniscal repair system segment is likely to hold the major share of the market in 2022

Based on product type, the Meniscus Repair System Market is segmented into an all-inside meniscal repair system, inside-out meniscal repair system, an outside-in meniscal repair system, and meniscal root repair system. The all-inside meniscal repair system segment is expected to dominate the market during the forecast period. All-inside meniscal repair technologies decrease technical difficulties, surgical time, and neuro-vascular structural danger. Furthermore, such technologies eliminate the hazards related to secondary incisions, shorten operational times, and make implant placement easier. As a result, increased benefits associated with all-inside meniscus repair methods, as well as a spike in its adoption rate, are expected to boost segment growth.

The radial tier segment is likely to hold the major share of the market in 2022

By application, the market is classified into radial tear, flap tear, horizontal tear, complex tear, and others. The radial tear segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. Radial meniscus tears have grown increasingly prevalent, particularly in sports traumatology. According to Johns Hopkins Medicine, nearly 3.5 million children aged 14 and under are injured each year while participating in leisure activities or sports. Suture method advancements in healing radial meniscal tears are expected to drive market expansion.

The hospitals segment is likely to hold the major share of the market in 2022

Based on end-user, the Meniscus Repair System Market is segmented into hospitals, ambulatory surgical centers, specialized orthopedic clinics, and others. In 2022, the hospitals segment dominated the market in terms of revenue and is expected to be the same during the upcoming years. This is because of the expanding number of healthcare facilities that have technologically improved technologies for performing knee-related meniscal operations. According to WHO data, 73% of highly specialized hospitals conducted more than 3000 procedures each year, compared to 18% of low-specialization institutions. Furthermore, expanding health insurance for the patient population is predicted to increase the number of surgical operations, boosting market development.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Meniscus Repair System Market value followed by Asia Pacific. This is due due to an increase in the number of people suffering from orthopedic illnesses such as osteoarthritis and sports-related injuries. Furthermore, an increase in the number of meniscus repair procedures is expected to boost market development. For example, according to the Journal of Orthopaedic Research, released in March 2021, over 8,50,000 meniscus repair procedures were conducted in the United States each year. Furthermore, an increase in the frequency of sports injuries leads to an increase in the prevalence of meniscus tears. As a result, this aspect is expected to boost market expansion. For example, according to data released by Johns Hopkins Medicine, more than 3.5 million children aged 14 and younger are injured each year while participating in sports or leisure activities. As a result, this factor increases the likelihood of knee injuries and meniscus tears, fueling market expansion.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS25735/

Competitive Landscape

The key players studied in the global Meniscus Repair System Market are Healthium Medtech , Smith & Nephew plc, Stryker Corporation , Arthrex, Inc. , Double Medical Technology Inc. , Zimmer Biomet Holding Inc., Arcuro Medical, Chetan Meditech Pvt. Ltd., Johnson & Johnson, and CONMED Corporation others.

Meniscus Repair System Market: Recent Developments

• In 2022, For treating meniscus joints, Arthrex, Inc designed an anterior approach with the FiberStitch implant. The FiberStitch implant is a novel all-inside meniscal repair technique that uses soft suture sheaths instead of hard PEEK implants. The 2-0 FiberWire suture is used for arthroscopic all-suture meniscus repair.
• In July 2021, Smith & Nephew plc has introduced the FAST-FIX FLEX meniscal repair technology, which has a bending needle and shaft. It is utilized in meniscus repair and offers patients long-term advantages. As a result, the introduction of the FAST-FIX FLEX Meniscal Repair System will assist the firm in establishing a solid presence in the meniscus repair system industrial market.
• In June 2020, Arcuro Medical collaborated with Genesis Biologics, a healthcare supply firm, to promote and sell the SuperBall meniscus repair device throughout the United States. As a result, this aspect is related to the growth of the meniscus repair system market.

Meniscus Repair System Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Meniscus Repair System Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Meniscus Repair System Market in terms of revenue ($Billion).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Meniscus Repair System industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Meniscus Repair System Market along with the current trends and future estimations to depict imminent investment pockets. The overall Meniscus Repair System industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Meniscus Repair System Market are also analyzed.

Meniscus Repair System Market Segmentation

By Product Type

• All-inside Meniscal Repair System
• Inside-out Meniscal Repair System
• Outside-in Meniscal Repair System
• Meniscal Root Repair System

By Application

• Radial tear
• Horizontal tear
• Vertical tear
• Complex tear
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Orthopedic Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Healthium Medtech
• Smith & Nephew plc
• Stryker Corporation
• Arthrex, Inc.
• Double Medical Technology Inc.
• Zimmer Biomet Holding Inc.
• Arcuro Medical
• Chetan Meditech Pvt. Ltd.
• Johnson & Johnson
• CONMED Corporation

Telemedicine Market to Reach US$ 94.5 Bn by 2032, driven by increasing demand for radiological services owing to high prevalence of chronic diseases: Global Insight Services

New York, August 2023: According to a new research study by Global Insight Services (GIS), the global telemedicine market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 94.5 Billion by 2032.

Telemedicine, also known as telehealth or e-medicine, is the remote delivery of healthcare services via telecommunications infrastructure, such as exams and consultations. According to recent research, 90% of organisations have already started or implemented telemedicine programmes. Even small, independent medical practises are beginning to embrace telemedicine in order to compete with local retail clinics and stop losing patients.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10073/

Telemedicine Market: Key Trends and Drivers

Surging prevalence of chronic diseases and cost-benefits of telemedicine will propel the market expansion. For instance, according to the US CDC, chronic diseases are major causes of death and disability globally and are strong contributors to the rise in annual healthcare expenditures. The management of chronic diseases requires constant monitoring and therapy to slow their progress. Telehealth and telemedicine, especially remote patient monitoring (RPM)/tele-homecare, are capable of improving patient self-management, medication compliance, clinical outcomes, and patient & provider satisfaction while reducing emergency room visits, hospital admissions, primary care utilization, long-term care, home admissions, and patient travel costs. These advantages are driving the demand for telehealth among end-users.

Telemedicine Market: Restraints & Challenges

Healthcare fraud is an important factor to consider in telehealth and telemedicine practises. A patient or a physician can be victimised in a variety of ways, such as when the physician’s name and accounts are used to receive payments from the insurance company, or when non-eligible or non-listed institutional providers practise improper coding and billing for false claims. Such fraudulent activities can erode trust and credibility in telehealth and telemedicine services. Victimized patients also have a tendency to share their negative experiences in the media, which affects many new entrants, limiting market growth.

Telemedicine Market Report Findings

https://www.globalinsightservices.com/reports/telemedicine-market/

The telemonitoring segment is likely to hold a dominant telemedicine market share and grow at a substantial CAGR during the forecast period.

Based on service, it is segmented into the tele-consulting, tele-monitoring, and tele-education/training. The tele-consulting segment accounted for the largest share of the global telemedicine market in 2022. The large share of the segment can be attributed to the growing demand for home-based remote monitoring service will boost the number of tele-consultations. Moreover, rising geriatric population base and increasing demand for home-based remote monitoring service. Remote telehealth monitoring programs are been initiated by several governments that focused on improving medication management and improves disease management at homecare setting. This will increase the demand for tele-consultation service. Furthermore, increasing need for providing healthcare services to patient at remote places coupled with rising demand for saving travel time will propel the segment growth.

The telehome segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on type, it is segmented into telehospital, and telehome. The telehospital segment is likely to dominate the market during the forecast period. This is due to increasing adoption and usage of telemedicine services in hospital setting to consult various specialists by doctors. This will result in cost savings for the hospitals as well as for the patients. The convenience and efficiency offered by telehospital services, such as remote consultations, virtual monitoring, and remote diagnostic capabilities, have garnered substantial attention from both healthcare providers and patients. The segment’s growth is expected to persist as advancements in technology, regulatory support, and the increasing acceptance of remote healthcare services continue to drive its adoption, ultimately reshaping the way healthcare is accessed and delivered on a global scale. Also, increasing government funding and grants for encouraging adoption of telemedicine services in hospitals will boost the segment demand.

The gynaecology segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on specialty, it is segmented into cardiology, gynecology, neurology, orthopedics, dermatology, mental health, and others. The cardiology segment is likely to dominate the market during the forecast period. This is owing to high With advances in remote monitoring technology and the increasing adoption of virtual healthcare platforms, patients and healthcare providers are recognizing the convenience and effectiveness of remote cardiology consultations. Telecardiology offers timely access to expert cardiac care, especially for individuals in remote or underserved areas, enabling early diagnosis, continuous monitoring of chronic conditions, and post-operative follow-ups without the constraints of physical distance. This growth is driven by a combination of factors, including the rising prevalence of cardiovascular diseases, technological advancements, reimbursement support, and the ongoing global shift towards more personalized and accessible healthcare solutions. As the telemedicine landscape evolves, the cardiology specialty is poised to play a pivotal role in shaping the future of remote healthcare delivery.

The web/mobile segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on delivery mode, it is segmented into web/mobile and call centers. The web/mobile delivery mode segment is likely to dominate the market during the forecast timeframe. the growth of web and mobile delivery modes, reflecting the increasing preference for remote healthcare services. This trend is driven by the convenience and accessibility offered by these platforms, allowing patients to connect with healthcare professionals seamlessly from the comfort of their homes. The proliferation of smartphones, coupled with advanced web-based applications, has facilitated real-time consultations, remote monitoring, and prescription delivery, thus expanding the reach of healthcare services to a wider population. As technology continues to evolve and user-friendly interfaces become more prevalent, the web and mobile delivery segment is poised to continue its upward trajectory, reshaping the way healthcare is accessed and delivered.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the Ventilators market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific, is anticipated to be the fastest-growing regional market during the forecast period. This rapid growth can be attributed to the presence of a large patient population pool, increasing internet usage, and rapid demand for healthcare assistance, especially in the rural areas. Emerging economies including India and China are estimated to lead the regional market in the years to come. In March 2021, India Brand Equity Foundation (IBEF) reported that the Indian government launched a telemedicine service-eSanjeevani and completed around 3 million consultations across the nation.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10073/

Competitive Landscape

The global telemedicine market report includes players such as Koninklijke Philips (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Teladoc Health (US), American Well (US), and AMC Health (US), among other.

Recent Developments in the Telemedicine Market:

• In April 2022, Bayer announced that it is setting up 27 telemedicine centres in 12 districts across eight states in India over the next two years through Bayer Foundation India.
• In January 2022, SwiftMD, announced the launch of its newly designed website, SwiftMD.com, and telehealth app as part of a brand refresh.
• In December 2021, Mesmerize announced partnership with VSee. This partnership is aimed to provide additional platform for Mesmerize’s advertisers to reach healthcare providers and patients within Mesmerize’s network telehealth solutions to offer remote patient monitoring services. This partnership will deliver best in class telehealth care service offerings.
• In December 2021, AFC Industries acquired AALL AMERICAN Fasteners (AAF). This acquisition helped the firm to develop innovative and high performing healthcare telemedicine equipment.

Telemedicine Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Telemedicine Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Telemedicine Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Telemedicine industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country analysis is also presented in this report.
• Analytical depiction of the Telemedicine Market along with the current trends and future estimations to depict imminent investment pockets. The overall Telemedicine industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Telemedicine Market are also analyzed.

Global Telemedicine Market Segments

By Service

• Tele-consulting
• Tele-monitoring
• Tele-education/training
• Others

By Type

• Telehospital
• Telehome

By Specialty

• Cardiology
• Gynaecology
• Neurology
• Orthopaedics
• Dermatology
• Mental health
• Others

By Delivery Mode

• Web/Mobile
• Call centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players Profiled in the Report

• Koninklijke Philips (Netherlands)
• Medtronic (Ireland)
• GE Healthcare (US)
• Cerner Corporation (US)
• Siemens Healthineers (Germany)
• Cisco Systems (US)
• Asahi Kasei Corporation (Japan)
• Teladoc Health (US)
• American Well (US)
• AMC Health (US)

New York, August 2023: According to a new research study by Global Insight Services (GIS), the global women’s health diagnostics market is expected to grow rapidly over the next 10 years to reach a value of more than the US $49.0 billion by 2032.

The women’s health diagnostic is a diagnostics method including screening, testing and monitoring of various women’s health disorders such as ovarian cancer, breast cancer, menopause, pregnancy and cervical cancer. For the diagnosis of women’s health-related diseases, various types of tests are available including Breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing, and ovarian cancer testing are all part of the diagnostic process. To avoid complications and improve quality of life, tests for screening and detection of various disorders are required. Health tests are essential for maintaining good health as well as preventing and treating serious diseases.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10385/

Women’s Health Diagnostics Market: Key Trends and Drivers

The growing awareness and prioritization of women’s health issues, coupled with advancements in medical technology. As societies increasingly recognize the importance of gender-specific healthcare, there is a heightened demand for accurate and specialized diagnostics tailored to women’s unique physiological and reproductive needs. Innovations in diagnostic techniques, such as non-invasive prenatal testing, advanced imaging modalities, and personalized genetic screenings, empower healthcare providers to detect and manage conditions like breast cancer, cervical abnormalities, and pregnancy-related complications with higher precision and early intervention. This evolving landscape not only enhances patient outcomes but also fosters collaborations between healthcare stakeholders, leading to the development of novel diagnostic solutions that cater to the distinct healthcare requirements of women, ultimately driving the growth of the Women’s Health Diagnostics Market.

Women’s Health Diagnostics Market: Restraints & Challenges

IThe growth of the Women’s Health Diagnostics Market may encounter limitations due to the significant costs associated with diagnostic procedures and the relatively low awareness among women about the importance of such procedures. The high financial burden of diagnostic tests could dissuade many women from seeking timely and necessary screenings, thereby impeding early detection and intervention for various health conditions specific to women. Additionally, the lack of awareness regarding the significance of diagnostic procedures may result in a delayed response to potential health issues, hindering the market’s expansion. Addressing these challenges through targeted awareness campaigns, improved accessibility to affordable diagnostics, and enhanced education about women’s health could play a pivotal role in overcoming these constraints and fostering the growth of the market..

Women’s Health Diagnostics Market Report Findings

https://www.globalinsightservices.com/reports/womens-health-diagnostics-market/

Diagnostic Device segment is likely to hold a dominant women’s health diagnostics market share and grow at a substantial CAGR during the forecast period.

Based on type, it is segmented into the diagnostic devices, diagnostic tests, accessories and consumables. In 2022, the diagnostics devices segment was the significant revenue generator and it is anticipated to grow at the fastest growth rate during the forecast period. This is driven by advancing technology and increasing awareness of gender-specific healthcare needs. These devices, ranging from ultrasound systems tailored for obstetric and gynecologic imaging to sophisticated mammography equipment, have gained prominence due to their pivotal role in early detection and accurate diagnosis of various women’s health conditions, including breast cancer, cervical abnormalities, and reproductive disorders. As medical innovations continue to enhance the precision and accessibility of these devices, coupled with rising efforts to prioritize women’s health, the diagnostics devices segment is poised to further expand, ensuring improved healthcare outcomes for women worldwide.

The breast cancer segment is anticipated to hold a majority of the women’s health diagnostics market size throughout the study period.

Based on application, it is segmented into breast cancer, infectious disease testing, osteoporosis testing, pregnancy and fertility testing, sexually transmitted disease testing, other applications. The breast cancer segment is likely to dominate the market during the forecast period. The largest share of the breast cancer is the most commonly occurring cancer in women and the second most common cancer worldwide. According to Globocan 2020, there were around 2,261,419 new breast cancer cases in 2020. The increasing cases resulted in increased sales of test kits for home usage, which is also expected to drive the market’s revenue growth over the forecast period. The rise in the adoption of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging devices worldwide are expected to fuel the market growth.

The homecare settings segment is anticipated to hold a majority of the women’s health diagnostics market size throughout the study period.

Based on end-use, it is segmented into hospitals and clinics, diagnostic and imaging centers, homecare, others. The home care settings segment is expected to witness the highest growth during the forecast period. This expansion can be attributed to several factors, including increasing awareness among women about the importance of regular health check-ups, the convenience and comfort associated with receiving diagnostic services within the familiar setting of their homes, and the ongoing efforts to enhance patient-centric care. Additionally, the increasing advantages of using self-testing kits will continue to drive market growth. Patient self-testing enables patients to better manage their diseases by utilizing home/self-testing kits. Moreover, the COVID-19 pandemic further accelerated the adoption of home-based diagnostics, as many women sought safer alternatives to traditional healthcare facilities. Technological innovations such as portable ultrasound devices, at-home hormone level testing kits, and telemedicine platforms have empowered women to actively engage in monitoring their health, contributing to the growth of the homecare segment. As the healthcare landscape continues to evolve, the homecare segment is poised to play a pivotal role in the Women’s Health Diagnostics Market by providing personalized and accessible diagnostic solutions that cater to the unique needs of women, ultimately improving overall healthcare outcomes and quality of life.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the women’s health diagnostics market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is accounted for the majority of market share during the forecast period. The largest share of the region is primarily attributed to the favorable reimbursement policies for imaging procedures in the US, increased prevalence of cancer, and high investment by hospitals to purchase advanced diagnostics systems. Furthermore, increased research and development efforts have yielded innovative diagnostic tools tailored to women’s unique physiological needs, enabling more accurate and personalized assessments. The region’s robust healthcare infrastructure, coupled with substantial investments in healthcare research and development, has paved the way for the integration of cutting-edge technologies such as molecular diagnostics, advanced imaging modalities, and precision medicine approaches. As a result, the North American Women’s Health Diagnostics Market is witnessing substantial expansion, not only in terms of revenue but also in its ability to provide early detection and effective management of conditions such as breast cancer, cervical abnormalities, and hormonal imbalances, ultimately contributing to improved healthcare outcomes and enhanced quality of life for women across the continent.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10385/

Competitive Landscape

The global women’s health diagnostics market report includes players such as Abbott (U.S.), BD (U.S.), Cardinal Health, Inc. (U.S.), F.Hoffmann-La Roche Ltd. (Switzerland), General Electric Company (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Netherland), Quest Diagnostics Incorporated (U.S.), Siemens Medical Solutions USA, Inc. (Germany), and bioMérieux SA. (U.S.)

In addition, major vendors are focused on developing smarter technologies and devices for cancer and other disease diagnostics. For instance, in January 2021, Roche launched its CE-IVD approved automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis for breast cancer. This launch was anticipated to expand its customer base and market share.

Recent Developments in the Women’s Health Diagnostics Market:

• In September 2021, Abbott acquired Walk Vascular LLC, a commercial-stage medical device firm with a minimally invasive mechanical aspiration thrombectomy system for the removal of peripheral blood clots.
• In April 2021, Carestream Health entered a partnership with Ziehm Imaging to provide Ziehm Vision RFD C-arm, a surgical imaging system included in the company’s mobile and fluoroscopic product offerings for ensuring exceptional image quality and reducing exposure significantly.
• In July 2019, Paragon Biosciences LLC launched Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes.
• In June 2019, Genomic Health’s Oncotype DX Breast Recurrence Score test was approved by the German Federal Joint Committee for nationwide reimbursement.

Women’s Health Diagnostics Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Women’s Health Diagnostics Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Women’s Health Diagnostics Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Women’s Health Diagnostics industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Women’s Health Diagnostics Market along with the current trends and future estimations to depict imminent investment pockets. The overall Women’s Health Diagnostics industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Women’s Health Diagnostics Market are also analyzed.

Global Women’s Health Diagnostics Market Segments

By Type

• Diagnostic Devices
• Diagnostic Tests
• Accessories and Consumables

By Application

• Breast Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Sexually Transmitted Disease Testing
• Other Applications

By End-use

• Hospitals and Clinics
• Diagnostic and Imaging Centers
• Homecare
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players Profiled in the Report

• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health, Inc. (U.S.)
• F.Hoffmann-La Roche Ltd. (Switzerland)
• General Electric Company (U.S.)
• Hologic, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherland)
• Quest Diagnostics Incorporated (U.S.)
• Siemens Medical Solutions USA, Inc. (Germany)
• bioMérieux SA. (U.S.)

Smart Pills Market to Reach USD 14.3 billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Smart Pills market is expected to grow rapidly over the next 10 years to reach a value of more than USD 14.3 billion by 2032.

Small digital devices known as “smart pills” have a capsule-like shape and are supposed to conduct very complex tasks like sensing, imaging, and medicine administration. When swallowed, these capsules—which may contain a biosensor, an image sensor, a pH sensor, or a chemical sensor—travel along the gastrointestinal track to collect images that would be otherwise challenging to obtain. Additionally, smart pills come with a tiny wearable sensor patch that is linked to a provider portal and an app on a mobile device. These non-invasive tools have transformed how cancer and gastrointestinal problems are diagnosed and can take the place of more traditional diagnostic methods like endoscopy.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10448/      

Smart Pills Market: Key Trends and Drivers

One significant driver for the smart pills market is the growing demand for non-invasive and efficient drug delivery methods. Traditional oral drug administration often faces challenges, such as low patient compliance and inadequate absorption rates, which can affect treatment efficacy. Smart pills, equipped with innovative technologies like sensors and microprocessors, enable remote monitoring of medication intake, ensuring patients adhere to their prescribed regimens. Moreover, these pills can target specific areas within the body, releasing drugs at optimal locations for better absorption, thereby enhancing treatment outcomes. As healthcare providers and patients increasingly seek convenient and personalized healthcare solutions, the demand for smart pills is expected to rise, driving the growth of the smart pills market in the coming years.

Smart Pills Market: Restraints and Challenges

The rising concern over data privacy and security will restraint the smart pills market. Smart pills often utilize advanced technologies to track and transmit data, such as internal body conditions, medication adherence, and other vital health information. This real-time data collection raises apprehensions among consumers and healthcare professionals about potential breaches, unauthorized access, or misuse of sensitive medical data. Ensuring robust encryption, strict regulatory compliance, and implementing foolproof security measures are critical to address these concerns and gain trust in smart pill adoption. Failure to address these privacy and security issues adequately could hinder the widespread acceptance and adoption of smart pills, limiting their potential to revolutionize healthcare and patient monitoring.

Smart Pills Market Report Findings

https://www.globalinsightservices.com/reports/smart-pills-market/

The capsule endoscopy segment is anticipated to dominate the market during the forecast period

Based on the application, it is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is anticipated to dominate the market during the forecast period. Capsule endoscopy, a non-invasive medical imaging technology that utilizes miniature wireless cameras embedded in ingestible capsules, enables physicians to visualize the gastrointestinal tract in unprecedented detail. This innovative approach has gained substantial traction due to its patient-friendly nature, eliminating the need for traditional endoscopic procedures that can be uncomfortable and invasive. With increasing prevalence of gastrointestinal disorders and rising demand for minimally invasive diagnostic techniques, capsule endoscopy is poised to experience substantial growth in the smart pills market, offering promising prospects for improved patient care and medical advancements in this domain.

The esophagus segment is anticipated to dominate the market during the forecast period

Based on the target area, it is segmented into the esophagus, small intestine, large intestine, and stomach. The esophagus segment is anticipated to dominate the market during the forecast period. Smart pills, equipped with cutting-edge sensor and imaging technologies, have shown great potential in revolutionizing the diagnosis and treatment of esophageal disorders, enabling healthcare professionals to obtain real-time insights into the patient’s gastrointestinal health. These smart pills can precisely target the esophagus, monitoring and detecting abnormalities, such as growths and lesions, with unprecedented accuracy and minimal invasiveness. As the global healthcare industry continues to prioritize early detection and personalized treatment options, the rising adoption of smart pills for esophageal target area segment growth holds promise in enhancing patient outcomes, streamlining medical procedures, and ultimately contributing to improved overall healthcare management.

The esophageal diseases segment is anticipated to dominate the market during the forecast period

Based on the disease indication, it is segmented into esophageal diseases, small bowel diseases, colon diseases, and others. The smart pills market is witnessing significant growth in the small bowel diseases segment due to the rising prevalence of gastrointestinal disorders and advancements in medical technology. Smart pills equipped with advanced sensors and wireless communication capabilities offer a non-invasive and real-time monitoring solution for small bowel diseases, providing valuable insights into the patient’s digestive health. These smart pills can detect abnormalities, inflammation, and other gastrointestinal conditions in the small bowel, facilitating early diagnosis and timely intervention. Additionally, the increasing adoption of smart pills by healthcare providers to improve patient outcomes and reduce the need for invasive procedures further propels the market growth in the small bowel diseases segment. As a result, the integration of smart pills into the management of small bowel diseases is anticipated to drive substantial market expansion in the coming years.

The hospital end user segment is anticipated to dominate the market during the forecast period

Based on the end user, it is segmented into hospitals, diagnostic centers, and research institutes. The hospital segment in the smart pills market has witnessed remarkable growth over recent years, fueled by the increasing adoption of advanced healthcare technologies and the rising prevalence of chronic diseases worldwide. Smart pills offer significant advantages in monitoring patient health, enabling real-time data collection, and improving diagnostic accuracy. Hospitals are increasingly embracing these innovative ingestible devices to enhance patient care, track medication adherence, and optimize treatment outcomes. Additionally, the integration of smart pill technologies into hospital settings has streamlined healthcare workflows, leading to improved patient management and operational efficiencies. With the continuous advancements in smart pill technology and a growing focus on patient-centric healthcare, the hospital segment is poised to experience further expansion, revolutionizing the way medical professionals diagnose and treat patients.

The North American region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. This is driven by advancements in healthcare technologies and an increasing emphasis on non-invasive and remote patient monitoring solutions. The region’s well-established healthcare infrastructure, coupled with a rising prevalence of chronic diseases and a growing elderly population, has further accelerated the adoption of smart pills as a promising diagnostic and therapeutic tool. Additionally, favorable government initiatives supporting digital health technologies and the presence of key market players investing in research and development have contributed to the region’s substantial expansion in the smart pills market. With a growing awareness among healthcare professionals and patients about the benefits of smart pills, North America continues to lead in this innovative sector, poised for continued growth and transformative impact on patient care and medical practices.

Moreover, medical researchers ongoing progress in the area of ingestible electronics is what is fueling this growth. The U.S. FDA and other regional agencies have been developing standards for obtaining approvals for digital smart tablets. Over the anticipated period, such actions are anticipated to fuel regional growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10448/

Competitive Landscape

The key players studied in the report are Olympus Corporation, Proteus Digital Health Inc., CapsoVision Inc., MEDTRONIC, FUJIFILM Holdings Corporation, RF Co. Ltd., Check-Cap, BDD Limited, JINSHAN Science & Technology, and MEDISAFE among others.

Recent Developments

• In January 2021, etectRx, Inc., entered into a partnership agreement with Pear Therapeutics, Inc., for the development of two product candidate in the CNS space integrating adherence sensors and PDTs. The partnership is the first of its kind in exploring the usage of digital pill solutions with PDTs.
• In January 2019, Proteus Digital Health launched its first digital cancer chemotherapy pill in the market with an aim to help oncologists track treatment effectiveness and adherence in the cancer patient.
• In October 2018, Proteus Digital Health expanded its partnership with Otsuka Pharmaceutical in order to continue the development and commercialization of its ingestible sensor pill platform.
• In September 2017, Capso Vision Inc., announced the U.S. launch of Capso Cloud, a managing system that allowed physicians to extract data from the Capso Cam Plus smart pill eliminating the need to process capsule post-ingestion.

Smart Pills Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Smart Pills market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Smart Pills market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Smart Pills market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Smart Pills industry.

Global Smart Pills Market Segmentation

By Application

• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By Disease Indication

• Esophageal Diseases
• Small Bowel Diseases
• Colon Diseases
• Others

By End User

• Hospital
• Diagnostic Center
• Research Institute

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Olympus Corporation
• Proteus Digital Health Inc.
• CapsoVision Inc.
• MEDTRONIC
• FUJIFILM Holdings Corporation
• RF Co. Ltd.
• Check-Cap
• BDD Limited
• JINSHAN Science & Technology
• MEDISAFE

Oscillating Positive Expiratory Pressure Devices Market to reach US$ 208.9 Mn by 2032, driven by increasing prevelance of COPD in emerging countries: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Oscillating Positive Expiratory Pressure Devices market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 208.9 Mn by 2032.

The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs’ walls.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10444/

Oscillating Positive Expiratory Pressure Devices Market: Key Trends and Drivers

The increasing prevalence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has led to a surge in demand for mucous clearing devices, with oscillating positive expiratory pressure (OPEP) devices spearheading the growth of the market. These conditions often result in the accumulation of thick mucus in the airways, leading to breathing difficulties and decreased lung function. OPEP devices offer an effective solution by generating oscillations during exhalation, which helps to mobilize and loosen the mucus, facilitating its removal and improving airway clearance. As awareness of the benefits of these devices continues to spread among healthcare professionals and patients alike, the OPEP devices market is poised to experience significant expansion to meet the rising needs of individuals seeking better management of cystic fibrosis and COPD.

Oscillating Positive Expiratory Pressure Devices Market: Restraints & Challenges

The oscillating positive expiratory pressure (OPEP) devices market is facing challenges in its growth trajectory, primarily due to two key factors: low awareness and high cost. Despite the potential benefits these devices offer in improving respiratory health, there remains a lack of sufficient awareness among healthcare professionals and patients alike. This limited awareness hampers the adoption of OPEP devices, as potential users may not fully understand their advantages. Moreover, the relatively high cost associated with these devices also acts as a significant restraint on market growth, making them less accessible to a broader population. To overcome these obstacles, concerted efforts are required from manufacturers and healthcare stakeholders to increase awareness through educational initiatives, while also exploring avenues to make these devices more cost-effective and affordable to a consumers.

Oscillating Positive Expiratory Pressure Devices Market Report Findings

https://www.globalinsightservices.com/reports/oscillating-positive-expiratory-pressure-devices-market/

The mouthpiece PEP device segment is likely to hold a dominant Oscillating Positive Expiratory Pressure Devices market share and grow at a substantial CAGR during the forecast period.

Based on the product type, it is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment is anticipated to dominate the market during the forecast period. These innovative devices have garnered widespread attention and adoption among patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The mouthpiece PEP devices offer several advantages, including enhanced portability, ease of use, and improved patient compliance compared to traditional mask-based PEP devices. Moreover, their ability to effectively mobilize mucus, improve lung function, and reduce the risk of respiratory infections has further fueled their popularity. As healthcare providers and patients increasingly recognize the benefits of mouthpiece PEP devices, their rising demand is expected to drive remarkable growth in the oscillating PEP devices market, ultimately revolutionizing respiratory care and management for those in need.

The COPD & Asthma segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.

Based on the indication, it is segmented into COPD & asthma, bronchitis, cystic fibrosis, and others. The COPD & Asthma segment is anticipated to dominate the market during the forecast period. Due to the primary reason of tobacco use, COPD is brought on by airway blockage that makes breathing difficult. The third leading cause of death worldwide in 2019 is a chronic obstructive pulmonary disease, according to a report from the World Health Organization. Over the projected period, the segment’s growth is anticipated to be boosted by increasing patient awareness of the need to create a unified platform for COPD sufferers. For instance, worldwide, November is recognized as National COPD Month. The COPD (chronic obstructive pulmonary disease) Foundation teams up with a number of respiratory healthcare organizations to organize a number of online and offline events for COPD community members to increase exposure. heance, all such factor will fuel the segment as well as market growth.

The hospitals & clinics segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.

Based on end user, it is segmented into hospital & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to dominate the market during the forecast period. Hospital oscillating positive expiratory pressure (OPEP) devices are expected to be more in demand as a result of the increase of hospitals, especially in developed countries. Furthermore, the segment’s growth is supported by the presence of a well-developed infrastructure and the availability of cutting-edge equipment. Additionally, as more patients are admitted to hospitals, these devices are used more frequently, which boosts revenue in hospital pharmacies.

Moreover, increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis has led to a rise in the demand for effective airway clearance devices in medical settings. OPEP devices have gained popularity in hospitals and clinics due to their ability to help patients clear mucus from their airways, improve lung function, and reduce the risk of exacerbations. Additionally, advancements in technology and the introduction of portable and user-friendly OPEP devices have further fueled their adoption in healthcare facilities. As a result, the hospital and clinics segment is expected to continue experiencing positive growth as healthcare providers recognize the importance of these devices in enhancing respiratory care and patient outcomes.

The Asia Pacific region is estimated to exhibit the highest growth rate during the Oscillating Positive Expiratory Pressure Devices market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Asthma affects 1 in 13 persons, according to a 2019 report from the Centers for Disease Control and Prevention (CDC). Asthma affects more than 25 million Americans. This represents 8.4% of kids and 7.7% of adults. All age, sex, and racial groups have shown an increase in asthma cases since the early 1980s. The American Academy of Allergy, Asthma and Immunology (AAAI) estimates that in 2016, 8.3% of American children were diagnosed with asthma. Boys had an overall higher prevalence of asthma than girls, with rates of 9.2% and 7.4%, respectively. Children’s asthma incidence rose from 8.7% in 2001 to 9.4% in 2010, then fell to 8.3% in 2016. Though not all adjustments were statistically significant. Thus, aforementioned factors will drive the market growth in North America during the forecast period.

Moreover, OPEP devices are increasingly recognized as effective respiratory therapy tools for patients with various pulmonary conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The rising prevalence of respiratory disorders, coupled with the growing geriatric population, has fueled the demand for these devices in the region. Additionally, advancements in technology, leading to the development of more user-friendly and portable OPEP devices, have further driven market adoption. Moreover, an increasing focus on home-based healthcare solutions and a growing emphasis on preventive care are likely to bolster the market’s expansion. As a result, key market players are investing in research and development activities to innovate and launch new OPEP devices, thereby contributing to the market’s growth in North America.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10444/

Competitive Landscape

The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

Recent Developments in the Oscillating Positive Expiratory Pressure Devices Market:

• In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
• In May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ desire to drive process efficiencies and value driven healthcare spending.
• In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
• In February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk.

Oscillating Positive Expiratory Pressure Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Oscillating Positive Expiratory Pressure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Oscillating Positive Expiratory Pressure Devices Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Oscillating Positive Expiratory Pressure Devices industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Oscillating Positive Expiratory Pressure Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall Oscillating Positive Expiratory Pressure Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Oscillating Positive Expiratory Pressure Devices Market are also analyzed.

Global Oscillating Positive Expiratory Pressure Devices Market Segmentation

By Product Type

• Face Mask PEP Devices
• Mouthpiece PEP Devices
• Bottle PEP Devices

By Indication

• COPD & Asthma
• Bronchitis
• Cystic Fibrosis
• Others

By End User

• Hospital & Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• AirPhysio
• Allergan plc.
• D-R Burton Healthcare
• Medica Holdings, LLC.
• Monaghan Medical Corporation
• PARI GmbH
• R. Cegla GmbH & Co. KG
• Smiths Medical, Inc.
• WyMedical Pty Ltd
• Smiths Medical, Inc.

Hearing Aids Market to Reach USD 15.6 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global hearing aids market is expected to grow rapidly over the next 10 years to reach a value of more than USD 15.6 billion by 2032.

A hearing aid is an electronic device made to improve hearing in people who have hearing loss or damaged auditory nerves. Hearing device use is anticipated to increase with the rising prevalence of hearing loss. For instance, 1.1 billion young people (aged 12-35) are at risk of hearing loss as a result of exposure to noise in recreational contexts, according to 2020 WHO publications on deafness and hearing loss.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10291/

Hearing Aids Market: Key Trends and Drivers

It is vital to monitor and analyze hearing functions due to the increased prevalence of hearing loss in the world. Untreated hearing loss in children has a detrimental influence on social interaction, learning, and language development. Similar to younger folks, older adults with hearing loss frequently struggle to follow daily conversations. Untreated hearing loss has been associated with a number of medical and mental problems in older adults, including depression and cognitive decline as well as a higher risk of trips and falls. Likewise, Major market participants have significant growth prospects in emerging economies like South Korea, Malaysia, Vietnam, South Korea, Africa, Israel, Saudi Arabia, and the United Arab Emirates. This is due to factors such as their lax regulatory requirements, improved healthcare facilities, expanding patient populations, and rising healthcare costs. Additionally, compared to industrialized nations, the regulatory regulations in the Asia-Pacific area are more flexible and business-friendly. This has led major companies in the hearing aids industry to concentrate on growing nations, along with the escalating competition in mature areas.

Hearing Aids Market: Restraints and Challenges

A significant factor limiting market growth is the high cost of hearing aids, including cochlear implants and bone-anchored systems, particularly in price-sensitive regions like the Asia Pacific, Latin America, and Africa. Healthcare providers generally lack the financial resources to invest in sophisticated technologies, particularly in developing nations like Brazil and Mexico. Additionally, the staff must receive comprehensive training in the proper handling and upkeep of bone-anchored devices and cochlear implants. Technology-advanced hearing aids must be developed through extensive R&D efforts. As a result, both the manufacturing cost and the final price for clients increase significantly. As a result, patients must pay a proportionally high price for the related surgical interventional treatments and diagnostic testing.

Hearing Aids Market Report Findings

https://www.globalinsightservices.com/reports/hearing-aids-market/

The behind-the-ear segment accounted for the largest revenue share of the market during the forecast period

Based on product type, it is segmented into in-the-ear, receiver-in-the-ear, behind-the-ear, and canal. The behind-the-ear segment accounted for the largest revenue share of the market during the forecast period. BTE hearing aids are made up of a compact, curved housing that fits behind the ear with ease. By attaching them to external sound sources like infrared listening devices and auditory training apparatus, these goods can be modified. Different BTE versions support Bluetooth, which improves wireless connectivity and drives the market. Because they have a powerful amplifier and a large battery, these gadgets also have a stronger sound amplification. Additionally, behind-the-ear (BTE) devices can fit into a variety of ear molds, are simple to use and clean, and are more popular among younger people. Additionally, they don’t need to be replaced as the youngster gets older. With the development of new technologies, smaller, more comfortable devices like the Mini BTE are created. Various elements have contributed to the market expansion of these BTE products.

Digital devices segment dominated the market during the forecast period

Based on technology, it is segmented into analog, and digital. Digital devices segment dominated the market during the forecast period. With a slower growth rate than their digital counterparts, analog gadgets are close to being outdated. Despite this, producers still make analog hearing aids due to their low cost and a small number of consumers’ resistance to switching to digital ones. On the principle of amplifying continuous sound waves, analog devices operate. In these goods, all sounds, including speech and noise, are amplified uniformly. Due to the presence of an inbuilt microchip that enables the programming of various settings for various listening conditions, a few analog devices are programmable.

The retail segment dominated the market during the forecast period

Based on sales channel, it is segmented into retail sales, government purchases, and E-commerce. The retail segment dominated the market during the forecast period. One of the key drivers of a significant portion of retail sales is the availability of over-the-counter hearing aids. Over the projected period, e-commerce and government purchases of these gadgets are anticipated to expand at a profitable rate. A huge number of retail establishments, an increase in manufacturing companies entering the retail sales market, and a high sales margin are all factors that have contributed to the retail sales segment’s rise. These products retail sales are further divided into company-owned and independent retail outlets. Due to the market’s low barriers to entry for new retailers, strong profit margins, and extensive consumer interaction, independent retail stores predominated.

The Europe region dominated the market during the forecast period

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Europe dominated the market with a significant revenue share in 2022.  An increase in the prevalence of auditory loss and a rise in awareness regarding technological advancements are the major factors driving the demand for these devices in Europe. In addition, the growth of the audiology devices market in this region depends on the reimbursement policies of each European nation. According to the WHO’s 2021 report about Hearing, 196 million people in the WHO area of Europe had some hearing impairment, with 57.3 million (6.2%) having a severe or higher degree of hearing impairment.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10291/

Competitive Landscape

The key players studied in the market are Sonova Group, Demant A/S, GN Store Nord A/S, Cochlear Ltd., RION Co., Ltd., Starkey, Nurotron Biotechnology Co., Ltd., MED-EL, Audina Hearing Instruments, Inc., Elkon Pvt. Ltd., WS Audiology A/S, Eargo, Inc. and Horentek among others.

Recent Developments

• September 2021, Audientes, a company offering lower cost hearing aids to low-income countries, entered into a partnership with Hearing Wellness Clinic, a chain of hearing centers in South India, to introduce its self-adjusting hearing aids to the Indian market.
• August 2021, Phonak launched Audeo Life, the world’s first waterproof rechargeable hearing aid.
• May 2021, Bose entered into the over-the-counter hearing aids category by selling sound-controlled hearing aids directly to patients who suffer from mild to moderate hearing loss.
• February 2021, GN Hearing launched Re Sound Key, a hearing aid line-up that provides greater access to its proven and award-winning hearing technology across the globe.
• October 2020, Starkey partnered with Or Cam Technologies to provide assistive technologies to hearing and visually impaired people. This partnership enhanced or Cam’s ability to apply the advanced computer vision and machine learning methods that they had developed to transmit the visual world through audio, in collaboration with Starkey’s Livio Edge AI hearing aids.
• July 2020, Cochlear Ltd. Received US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and custom Sound Pro fitting software.

Hearing Aids Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Hearing Aids Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Hearing Aids Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hearing Aids Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Hearing Aids Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hearing Aids industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hearing Aids Market are also analyzed.

Global Hearing Aids Market Segmentation

By Product Type

• In-the-Ear
• Receiver in-the-Ear
• Behind-the-Ear
• Canal

By Technology Type

• Analog
• Digital

By Sales Channel

• Retail Sales
• Government Purchases
• E-commerce

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Sonova Group
• Demant A/S
• GN Store Nord A/S
• Cochlear Ltd.
• RION Co., Ltd.
• Starkey
• Nurotron Biotechnology Co., Ltd.
• MED-EL
• Audina Hearing Instruments, Inc.
• Elkon Pvt. Ltd.
• WS Audiology A/S
• Eargo, Inc.
• Horentek

Hospital Acquired Infection Control Market to Reach USD 26.8 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global hospital-acquired infection control market is expected to grow rapidly over the next 10 years to reach a value of more than USD 26.8 billion by 2032.

Nosocomially acquired illnesses that are not present or incubating at the time of admission to a hospital are known as hospital-acquired infections (HAIs). These infections include bloodstream infections linked to central lines, urinary tract infections linked to catheters, surgical site infections, pneumonia linked to ventilators, pneumonia acquired in hospitals, and infections with Clostridium difficile. A productive cough, shortness of breath, abdominal discomfort, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness are signs that an infection is present.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10297/

Hospital Acquired Infection Control Market: Key Trends and Drivers

Some of the major factors driving this market are rising awareness about Hospital Acquired Infections (HAIs), the need to prevent cross-infections, the incidence of infectious diseases in healthcare facilities, and supportive government programs to encourage infection control techniques. The development of national, regional, and hospital-level infection prevention guidelines and policies as well as the expanding use of monitoring tools are both contributing to the expansion. Similarly, the market for hospital-acquired infection control is anticipated to grow as a result of factors including the increased demand for sterilization and disinfection in hospitals and clinics, technological developments in sterilization and disinfection equipment, an increase in hospitals outsourcing sterilization services to pharmaceutical and medical device companies, and an increase in the production of medical nonwovens and single-use products due to an increase in COVID-19 cases.

Hospital Acquired Infection Control Market: Restraints and Challenges

The market for hospital acquired infection control is predicted to rise, but this expansion is expected to be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed instruments. In contrast, it is anticipated that the growing use of single-use medical nonwovens and devices would present profitable prospects during the projection period.

Hospital Acquired Infection Control Market Report Findings

https://www.globalinsightservices.com/reports/hospital-acquired-infection-control-market/

The protective barrier segment is anticipated to dominate the market during the forecast period

Based on the product & services, it is segmented into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. The protective barrier segment is anticipated to dominate the market during the forecast period. This is attributed to an increase in the general public’s awareness of personal hygiene, an increase in surgical procedures, a rise in the use of medical nonwovens, such as face masks, surgical drapes, and gowns, as a result of an increase in COVID-19 cases, and an increase in the manufacturing of gloves and nonwoven products.

The hospital-acquired pneumonia segment is expected to dominate the market during the forecast period

Based on the infection type, it is segmented into hospital-acquired pneumonia, bloodstream infections, surgical site infection, gastrointestinal infections, urinary tract infections, and others. The hospital-acquired pneumonia segment is expected to dominate the market during the forecast period. Some of the major factors driving this market include rising awareness regarding Hospital Acquired Infections (HAIs), the requirement to prevent cross-infections, the prevalence of infectious diseases in healthcare facilities, and encouraging government initiatives to promote infection control practices.

The hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market

Based on the end user, it is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market. Due to an increase in the number of surgical procedures performed in hospitals, an increase in the prevalence of hospital-acquired infections, an increase in the number of hospitals and clinics, and an increase in the number of elderly people, who also have an increase in the prevalence of chronic illnesses.

North America dominated the market and accounted for the largest revenue share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market and accounted for the largest revenue share in 2021. The presence of important companies, the initiatives they launched in the public and private sectors, and the rising awareness of HAIs in this area are all factors that contribute to the big share. For instance, the American-based Ecolab purchased the Swiss company vanBaerle Hygiene AG in December 2020. This expanded the product portfolio and service capabilities of Ecolab by providing a broad spectrum of cleaning, disinfection, and hygiene solutions. The CDC is in charge of epidemic investigations, surveillance, research, and HAI prevention in the United States. In accordance with the HHS Action Plan to Avoid Healthcare-Associated Infections in Acute Care Hospitals, the CDC also develops novel methods to prevent infections related to healthcare. In the upcoming years, it is anticipated that supportive measures like these will fuel regional growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10297/

Competitive Landscape

The key players analyzed in the market are Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, and Bayer AG among others.

Recent Development

• September 2021, Sodexo has expanded its partnership with Ecolab in the United States for the control of hospital-acquired infections through the Protecta Plus programme. This programme was created to reduce infection risk in hospitals and healthcare facilities by utilizing Ecolab’s Bioquell hydrogen peroxide vapor technology.
• July 2021, UVision 360 Inc. announced that it had received approval for the expansion of reprocessing procedures for utilization with the Luminelle DTx system.
• April 2020, Allegheny Health Network (AHN), announced a sterilization process that would allow the reuse of N95 masks that were very crucially in demand.
• April 2020, Steris received Emergency Use Authorization (EUA) from the U.S. FDA for respirator decontamination. This allowed the company to temporarily offer a solution for decontamination of compatible N95 or N95-equivalent respirators using STERIS V-PRO Low Temperature Sterilization Systems.

Hospital Acquired Infection Control Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Hospital Acquired Infection Control Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of the Hospital Acquired Infection Control Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hospital Acquired Infection Control Market industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Hospital Acquired Infection Control Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hospital Acquired Infection Control Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hospital Acquired Infection Control Market are also analyzed.

Global Hospital Acquired Infection Control Market Segmentation

By Products & Services

• Sterilization
• Cleaning & Disinfection Products
• Protective Barriers
• Endoscope Reprocessing Products

By Infection Type

• Hospital-acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTI)
• Others

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Olympus Corporation
• Medivators Inc. (Cantel Medical Corp.)
• Getinge Group
• STERIS Plc.
• Belimed AG (Metall Zug)
• Steelco S.P.A
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck & Co. Inc.
• Advanced Sterilization Products Services Inc. (Johnson & Johnson)
• Abbott Laboratories
• Bayer AG

Powered Wheelchair Market to Reach US$ 6.8 bn by 2032, driven by rapid advancement of flexible endoscope technology: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global powered wheelchair market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 6.8 bn by 2032.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24313/

Powered Wheelchair Market: Key Trends and Drivers

The rise in the older population and the prevalence of chronic diseases are both contributing to the rise in disability that is set to benefit the market. Electrical wheelchairs are thus used in hospitals and healthcare facilities to increase the welfare of patients and healthcare workers. According to figures given by the World Health Organization, the proportion of persons aged 65 and more in the world population will quadruple from 7% in 2000 to 16% by the end of 2050. By that time, the number of elderly persons in the population will outnumber youngsters (aged 0–14 years). The Office of National Statistics of the UK estimated the proportion of people aged 85 and above is set to be double in the next 25 years.

Powered Wheelchair Market: Restraints & Challenges

The powered wheelchair market is expected to be restrained by the lack of reimbursement policies for powered wheelchair across several countries. The powered wheelchair is a class II medical device in the US, which requires a physicians prescription for reimbursement from Medicare. In Europe, the powered wheelchair is classified as a Class I medical device, which allows for reimbursement from national health insurance systems. However, in several countries, there is no specific classification for powered wheelchair, which limits the reimbursement for the device. The powered wheelchair market is also expected to be challenged by the high cost of the device. The powered wheelchair can cost up to $20,000, which is not covered by Medicare or most private insurance plans. In addition, the powered wheelchair requires regular maintenance and upkeep, which can add to the overall cost of ownership.

Powered Wheelchair Market Report Findings

https://www.globalinsightservices.com/reports/powered-wheelchair-market/

The rear wheel segment is likely to hold a dominant powered wheelchair market share and grow at a substantial CAGR during the forecast period.

Based on product, the global powered wheelchair market is segmented into front wheel, mid wheel, rear wheel, and others. The rear wheel segment accounted for significant market share in the year 2022 and is expected to expand at a CAGR of 6.2% over the forecast period. Rear wheel drive (RWD) wheelchair is powered through the engine driving the rear wheels. These wheelchairs provide better control and power in fast corners, and do not lose traction as well. The rear-wheel-drive wheelchair spread the weight evenly as compared to its counterparts. The RWD are sturdy and are resistant to wear and tear. For instance, the Invacare Aviva Storm Rx power wheelchair is a RWD integrated with electronic control system, which can be used for indoor as well outdoor travel. According to the WHO 2021 statistics, more than 1 billion people worldwide are living with some form of disability. The prevalence of disability is vividly increasing due to the changing demographics, and rising burden of chronic diseases. Additionally, around 3.8% of the global population suffer from major difficulties in daily functioning and require assistance. Consequently, the rising burden of disability is set to propel the demand for powered wheelchair thereby fueling the market expansion over the analysis period.

The adult patient segment is anticipated to hold a majority of the powered wheelchair market size throughout the study period.

Based on the category, the powered wheelchair market is divided into adult, and pediatric. The adult patients using electric wheelchair accounted for significant market share in 2022. With the technological advancements in all the sectors over the past few years, the patients also show an increased tendency in accepting innovative products for their healthcare. Electric wheelchair has been in existence for a long time. But, in recent times, healthcare infrastructure has developed to a greater extent, accessibility to modern and quality healthcare, availability of innovative products and increased per capita income have directly affected the demand of these products. According to a research article, approximately three fourth of the geriatric population use the internet and are comfortable using smartphones. Thus, all the aforementioned factors contribute to the high share of adult patients using motorized wheelchair, thereby attributing to the powered wheelchair market development.

The homecare segment is anticipated to hold a majority of the powered wheelchair market size throughout the study period.

The electric wheelchair end-users are segmented into hospitals, homecare, ambulatory surgical centers, and rehabilitation centers. The homecare segment surpassed significant revenue share in 2022. Majority of the patients suffering from chronic conditions are hampering their mobility stay at home. Opting for homecare offers the patients advantages such as increased comfort, personalized care, family involvement, companionship, amongst others. A home care plan is tailored to your family’s needs rather than conforming to the schedules and routines of a care facility. Homecare facility can also be customized based on the patients need for assistance such as few hours, or full-time care. Therefore, owing to the various advantages, homecare segment will propel the industry expansion over the analysis period.

The Asia Pacific region is estimated to exhibit the highest growth rate during the powered wheelchair market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is projected to be the fastest-growing regional market over the forecast period. The region is backed by a large population base in countries, such as India and China, owing to the improvements in healthcare facilities and growing government initiatives for offering quality mobility devices. Moreover, the high geriatric population in countries, such as Japan, also supports market growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24313/

Competitive Landscape

The global powered wheelchair market report includes players such as Carex Health Brands, Inc., Drive Medical Design & Manufacturing, Graham-Field Health Products, Inc., Invacare, Medline, Sunrise Medical LLC., Karman Healthcare, Quantum Rehab, Numotion Pride, Mobility Products Corp, among Seating Matters among others. In addition, major vendors are focused on developing smarter technologies for surface disinfections.

Recent Developments in the Powered Wheelchair Market:

• In January 2022, Invacare Corp announced the launch of AVIVA STORM RX Narrow Base Power Wheelchair. This wheelchair is innovated to provide extra maneuverability and navigation to its standard counterpart. The addition of this product to their electric wheelchair portfolio helped the company to expand their portfolio as well as improve product penetration amongst diverse end users.
• In December 2021, Meyra Gmbh announced the launch of iChair Meylife, an intelligent power wheelchair. This product was introduced for patients suffering from tetraplegia, traumatic brain injury, paraplegia, Parkinsons disease, leg amputations and many more conditions. This product with its state-of-the-art capabilities will help the company generate revenue streams in the market.
• In July 2021, Sunrise Medical launched the QUICKIE Nitrum ultra-light wheelchair which offers the highest rigidity and strength.
• In January 2020, a U.S.-based startup, Segway, Inc., launched an egg-shaped pod that allows people to sit while they effortlessly cruise around campuses, theme parks, airports, and even cities. This pod can also be used by individuals with wheelchair needs and particularly caters for transportation with a high speed of 24 mph

Powered Wheelchair Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Powered Wheelchair Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of the Powered Wheelchair Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Powered Wheelchair Market industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Powered Wheelchair Market along with the current trends and future estimations to depict imminent investment pockets. The overall Powered Wheelchair Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Powered Wheelchair Market are also analyzed.

Global Powered Wheelchair Market Segmentation

By Product

• Front Wheel
• Mid Wheel
• Rear Wheel
• Others

By Application

• Adults
• Pediatric

By End-user

• Homecare
• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• Carex Health Brands, Inc.
• Drive Medical Design & Manufacturing
• Graham-Field Health Products, Inc.
• Invacare
• Medline
• Sunrise Medical LLC.
• Karman Healthcare
• Quantum Rehab
• Numotion Pride
• Mobility Products Corp
• Seating Matters

Germany Dental CAD-CAM Market to Reach US$ USD 281.7 Mn by 2032, driven Rising prevalence of dental disorders: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Germany Dental CAD-CAM Market is expected to grow rapidly over the next 10 years to reach a value of more than the USD 281.7 million by 2032.

CAD/CAM dentistry” refers to the software enabling dental practitioners to do complicated restorations more quickly, effectively, and occasionally even more precisely. Professionals conducting complex dental operations benefit from using software programs called computer-aided design (CAD) and computer-aided manufacturing (CAM). Restorations made of high-strength ceramic, such as crowns, inlays, onlays, veneers, bridges, dentures, and implant-supported restorations, are created by dental practices and laboratories using CAD/CAM technology.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24743/

Germany Dental CAD-CAM Market: Key Trends and Drivers

Rising prevalence of dental disorders

The rising incidence of dental infections and other periodontal diseases, the demand for dental care facilities, dental surgical procedures, and dental care staff, as well as technical improvements, all contribute to an increase in these conditions, which are some of the major factors propelling the growth of this market. Moreover, due to the growing aging population, there has been an increase in dental implants and oral surgeries being performed. According to the Germany Federal Statistical Office 2022 report, there are roughly 83.2 million people in Germany. Of these, 16.2 million people are over 67 years old, and this is expected to rise to 21.4 million by 2040. In addition, oral cavities are being impacted by a decline in manual dexterity, an increase in co-morbidity, and medication use. Hence, dental care in aged care facilities is found to be poor, and access to dental professionals is difficult. There are several other risk factors, such as smoking, poor oral hygiene, diabetes, medication, and hereditary conditions, which increase dental diseases.

Germany Dental CAD-CAM Market: Restraints & Challenges

High cost of dental CAD CAM system in Germany

The high cost of dental CAD CAM (Computer-Aided Design/Computer-Aided Manufacturing) systems in Germany is restraints the market growth. For instance, according to an article published by All3DP, the average selling price of a complete CAD/CAM system ranges in between USD 90,000.0 to USD 112,000.0 including cost of scanner, milling machine, and associated software.Dental CAD CAM systems are advanced technological solutions that allow for precise and efficient fabrication of dental prosthetics, such as crowns, bridges, and implants. However, these systems often come with substantial price tags, making them unaffordable for many dental practices, especially smaller ones or those in rural areas. The high initial investment required to purchase and set up a dental CAD CAM system, along with the ongoing maintenance costs, can be prohibitive for dentists and dental laboratories, limiting their ability to adopt this technology.

Moreover, the high cost of dental CAD CAM systems can also impact patients’ access to quality dental care. As dental practices bear the burden of the expensive equipment, they may pass on the costs to patients through higher prices for dental treatments involving CAD CAM restorations. This can make dental services less affordable for individuals, potentially leading to delayed or inadequate treatment, limiting the overall adoption and utilization of these systems in the dental industry.

Germany Dental CAD-CAM Market Report Findings

https://www.globalinsightservices.com/reports/germany-dental-cad-cam-market/

The In-lab Systems segment is likely to hold a dominant Germany Dental CAD-CAM Market share and grow at a substantial CAGR during the forecast period.

By Type, the Dental CAD/CAM market is segmented into In-lab Systems and In-office Systems. The In-lab Systems segment is anticipated to dominate the market during the forecast period. The segment was valued at USD 69.0 Million in 2017, and it is anticipated to grow further to USD 181.0 million by 2032, at a CAGR of 7.7% during the forecast period. Likewise, the In-office Systems segment is likely to witness the fastest growth during the forecast period by growing at a CAGR of 9.5% during the forecast period. The segment was valued at USD 29.6 million in 2017 and it is anticipated to grow further to USD 100.7 Million by 2032. The increasing number of dentists and dentistry offices in Germany is anticipated to enhance the market growth. For instance. In 2019, there were 98,604 registered dentists in Germany, of whom 72,589 were actively practicing. To practice, dentists must be accredited by the National Dental Association of Statutory Health Insurance (Kassenzahnärztliche Bundesvereinigung (KZBV)) and meet strict criteria. In fact, around 400 independent dental practices treat only privately insured patients in the country.

Moreover, the increasing demand for chairside systems will boost product use. Chairside CAD/CAM systems include a scanner and a milling device. The conventional impression is replaced by a digital optical impression, and in most cases, the prosthetic restoration is manufactured on the spot, which is a major time-saving advantage. This system provides unique benefits such as better patient comfort, reduce procedure time along with improved quality. they also offer competitive advantages to dentists by helping them provide digital service at a faster pace. Thus more dentists are adopting in-office or chairside systems, propelling the dental CAD/CAM industry growth in Germany.

The hardware segment is anticipated to hold a majority of the Germany Dental CAD-CAM Market size throughout the study period.

By component, the market is divided into hardware and software. The hardware segment is anticipated to dominate the market during the forecast period. Likewise, the software segment is anticipated to witness the fastest growth during the forecast period.

Hardware includes equipment such as milling machine, intraoral scanners, extra oral scanners, and many others. Rise in demand for intraoral scanners play a significant role as Intraoral scanners are commonly used in dentistry to capture direct optical imprints. To acquire high-speed imprints of teeth, most dentists employ cutting-edge intraoral scanners. Many makers of dental CAD/CAM systems are turning to an open design so that the software may be compatible with any milling device. Intraoral scanners and CAD improvements ensure patient safety while also enhancing patient results. These scanners’ accuracy, speed, and comfort for patients are all improving in order to serve a broader patient populated countries like Germany.

Additionally, the increase in demand for digital dentistry in Germany is one of the reasons to fuel the growth of the market. CAD/CAM technologies enable digital veneering workflow and automate the manufacture and quality standardization of dental restorations. As there are more active cases of dental caries and concerns of oral health can propel market’s growth in German region.

The dental clinics segment is anticipated to hold a majority of the Germany Dental CAD-CAM Market size throughout the study period.

By end-use, the Germany dental CAD-CAM market has been segmented into dental clinics, dental laboratories, and dental milling centers. The dental clinics segment is anticipated to dominate the market during the forecast period. Besides, the dental milling centers segment is likely to witness the fastest growth during the forecast period. Overall, CAD/CAM technology may assist dental clinics in treating patients more effectively, precisely, and affordably while enhancing the patient experience. Due to the excellent accuracy of CAD/CAM technologies, restorations fit better and clinical results are enhanced. Dental clinics may treat patients more quickly by using CAD/CAM technologies, which can drastically reduce the time needed to design and construct restorations. Restorations that are extremely accurate and complicated can be made with CAD/CAM technology, which may not be achievable with conventional methods. CAD/CAM systems can be a cost-effective option for dental clinics by minimizing the need for human labor and several sessions.

The patient experience can be enhanced using CAD/CAM technology to eliminate the requirement for dirty and unpleasant impression materials. With enhanced communication between the dentist clinic made possible by CAD/CAM technology, restoration turnaround times might be sped up. Highly customized restorations that match each patient’s unique demands can be made using CAD/CAM technologies. Therefore, the dental clinics segment has a significant market share.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24743/

Competitive Landscape

The key players in the Germany Dental CAD-CAM Market are Align Technology, Inc. (exocad GmbH), Ardian (imes-icore GmbH), Argen Dental GmbH, CADdent GmbH (DeguDent GmbH), Dentsply Sirona (Sirona Dental Systems, Inc.), INFINIDENT Solutions GmbH, Ivoclar Vivadent, Henry Schein, Inc. (BioHorizons, Inc.), Zimmer Biomet, Zirkonzahn srl., and 3M Company, among others.

Recent Developments in the Germany Dental CAD-CAM Market:

• In December 20222, Mindray introduces new wearable patient monitoring system, refining clinicia’s workflow to track patient conditions. “mWearTM” supports comprehensive and precise measurements of patient status, integrating 6 key vital signs powered by Anti-motion Algorithm, specialized health parameters, status indicators and time analysis. mWearTM features two monitoring modes, Wearable Mode and Continuous Mode, for caregivers to get patient status updates accordingly to the customize setting, and intelligently triggers emergencies and alarm escalations to ensure timely response to patient deterioration.
• In September 2022, Apple introduced Apple Watch Series 8 and the new Apple Watch SE, which bring ground breaking technology and performance, and important safety innovations to the two best-selling smartwatches. The new Apple Watch SE delivers the core Apple Watch experience, including Activity tracking, high and low heart rate notifications, and Emergency SOS, as well as the new Crash Detection feature.
• In August 2022, Medtronic plc announced the completion of its acquisition of Affera, Inc. This purchase broadens the company’s cardiac ablation offering by adding its inaugural cardiac mapping and navigation platform, which includes a distinct, fully integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.

Germany Dental CAD-CAM Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Germany Dental CAD-CAM Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Germany Dental CAD-CAM Market in terms of revenue ($Million)
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the UK Wearable Cardiac Devices industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Germany Dental CAD-CAM Market along with the current trends and future estimations to depict imminent investment pockets. The overall UK Wearable Cardiac Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Germany Dental CAD-CAM Market are also analyzed.

Germany Dental CAD-CAM Market Segmentation

By Type

• In-lab Systems
• In-office Systems

By Component

• Hardware
• Software

By End-user

• Dental Clinics
• Dental Laboratories
• Dental Milling Centers

Key Players

• Align Technology, Inc. (exocad GmbH)
• Ardian (imes-icore GmbH)
• Argen Dental GmbH
• CADdent GmbH (DeguDent GmbH)
• Dentsply Sirona (Sirona Dental Systems, Inc.)
• INFINIDENT Solutions GmbH
• Ivoclar Vivadent
• Henry Schein, Inc. (BioHorizons, Inc.)
• Zirkonzahn srl.
• Zimmer Biomet
• 3M Company

UK Wearable Cardiac Devices Market to Reach US$ 3,427.6 M by 2032, driven by growing attention on improving customer engagement process: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global UK Wearable Cardiac Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 3,427.6 million by 2032.

Wearable cardiac devices are intended to assist those with heart rhythm abnormalities in managing irregular heartbeats. The heart’s electrical system, which instructs the heart to contract and circulate blood throughout the body, is the source of these anomalies. Wearable technology is a creative answer to several problems in the healthcare sector. Additionally, employed to manage patients and diseases, wearable technology has the potential to influence clinical judgment significantly. Heart-related information may be calculated, displayed, and stored in real-time using wearable cardiac devices and medical gadgets worn on the body. These items include wristwatches, patches, and fitness trackers.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24744/

UK Wearable Cardiac Devices Market: Key Trends and Drivers

Rising cases of cardiovascular disorders in the UK

The rising cases of cardiovascular disorders in the UK have indeed been a major concern in recent years. Around 1.2 million people in the UK are registered with atrial fibrillation, with nearly half a million (422,600) predicted to have AF undiagnosed, according to Public Health England. And there are more than 100,000 strokes in the UK each year, causing 38,000 deaths, making it a leading cause of death and disability. These numbers highlight the scale of the problem and the need for effective prevention and management strategies. This alarming trend has put significant pressure on healthcare systems and has led to an increased focus on preventive care and monitoring. In response to this growth need, propelling the demand for wearable cardiac devices in the country.

Several factors contribute to the rising cases of cardiovascular disorders in the UK. One of the key drivers is an aging population. The UK has witnessed a steady increase in the average age of its citizens, and older adults are more susceptible to heart-related problems. Additionally, unhealthy lifestyle choices such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption are major risk factors for cardiovascular diseases. The prevalence of these risk factors in the population, coupled with the high-stress levels of modern life, contribute to the increasing burden of heart diseases.

UK Wearable Cardiac Devices Market: Restraints & Challenges

The high cost associated with wearable cardiac devices

The high cost associated with wearable cardiac devices in the UK is a significant factor restraining the growth of the market. These devices, which include wearable heart monitors, implantable cardioverter-defibrillators (ICDs), and cardiac rhythm management (CRM) devices, often come with a hefty price tag. The cost of development, manufacturing, regulatory compliance, and ongoing support services contribute to the overall expenses associated with these devices. As a result, the high prices pose a financial burden for patients, healthcare providers, and the National Health Service (NHS) in the UK, limiting the adoption and market growth of wearable cardiac devices.

One of the main reasons for the high cost of wearable cardiac devices is the research and development investment required to bring innovative technologies to market. Developing advanced sensors, miniaturized components, and reliable connectivity features involves substantial financial resources. Additionally, ensuring compliance with strict regulatory standards, such as obtaining necessary certifications, further adds to the expenses. The costs associated with clinical trials, testing, and obtaining regulatory approvals also contribute to the high price point of these devices, making them less accessible to a larger population.

UK Wearable Cardiac Devices Market Report Findings

https://www.globalinsightservices.com/reports/uk-wearable-cardiac-devices-market/

The holter monitor segment is likely to hold a dominant UK Wearable Cardiac Devices Market share and grow at a substantial CAGR during the forecast period.

By Device, the UK Wearable Cardiac Devices market is bifurcated into Holter monitors, patches, defibrillators, smartwatches, and others. The Holter Monitors segment is anticipated to grow at a rate of 20.5% during the forecast period. The Holter monitoring electrocardiogram records the heart rhythm for up to a few minutes whereas Holter monitoring records the rhythm for 24 hours. This helps to detect arrhythmias that may only occur at certain times. The growth of the Holter ECG monitoring segment is driven by a rise in the geriatric population, an increase in the prevalence of heart stroke, a surge in the number of patients suffering from hypertension, and an upsurge in the prevalence of obesity. Moreover, technological advancements and growth in awareness about the feasible use of these devices are other factors that contribute to the growth of the market. However, a lack of trained professionals, inappropriate healthcare infrastructure, and unsteady reimbursement policies are expected to hinder market growth. Conversely, advanced Holter monitors with enhanced sensitive algorithms for the automatic detection of arrhythmias offer lucrative growth opportunities for the market.

The home healthcare segment is anticipated to hold a majority of the UK Wearable Cardiac Devices Market size throughout the study period.

Based on Application, the UK Wearable Cardiac Devices market is segmented into home healthcare, remote patient monitoring, sports and fitness, and others. The UK wearable cardiac devices market size for the home healthcare segment grew at a rate of 20.4% from 2023 to 2032. The aging population’s growing desire for at-home healthcare segment will increase demand for wearable cardiac devices in the UK. It is driven mostly by the growing number of older adults with cardiovascular diseases. Additionally, wearable trackers offer effective heart rate monitoring and give users access to real-time data that assists in risk identification and lowers hospital visits. Wearable technology that continuously monitors heart problems at home will result in fewer hospital visits, increasing its popularity throughout the projection period. These technologies, designed to assist patients in their homes, allow people to get healthcare services without traveling to Hospitals or clinics. The home healthcare application includes equipment for respiratory treatment. The increased need for customized healthcare services and the aging population drives the demand for wearable medical equipment. IoT and AI technologies would also hasten the market’s growth for wearable home healthcare devices.

The home care segment is anticipated to hold a majority of the UK Wearable Cardiac Devices Market size throughout the study period.

The home care settings segment held the majority of the market share throughout the study period. Home care may be the answer to having the best quality of life possible. Through treatment provided in the security and comfort of home, it may facilitate safety, security, and enhanced independence; it can simplify the management of a continuing medical condition; it can assist in preventing needless hospitalization; and it can speed up recovery after an illness, accident, or hospital stay. Even when frailty is a problem, in-home care often results in better life satisfaction. Home care aids and preserves family unity. Families typically take a more active role in providing care and fostering close relationships with their loved ones. Home care professionals have developed effective models for illness management, medication management, behavioral education, and care coordination in recent years. They have set the bar for creative and economic applications of treatments and technology to provide high-quality, client-centered care throughout the healthcare delivery system.

The England country is estimated to exhibit the highest growth rate during the UK Wearable Cardiac Devices Market forecast period.

The wearable cardiac devices market in England is anticipated to grow at a CAGR of 19.0% from 2023 to 2032.. The number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other conditions of the heart patients in England is substantial. In accordance with the British Heart Foundation (BHF), there are over 7 million individuals living with CVD, and around 152,465 deaths are related to CVD. Critical risk factors for CVD, CHD, Stroke, and other heart diseases include detrimental stress, depression, excessive alcohol use, excessive smoking, high blood pressure, diabetes, obesity, and a poor diet that contains cholesterol. As a result, people were encouraged to prioritize preventative healthcare, which implies that people are spending a lot of money on smart wearable healthcare gadgets. This will fuel the expansion of wearable cardiac device industry.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24744/

Competitive Landscape

The key players in the UK Wearable Cardiac Devices Market are Boston Scientific Corporation, iRhythm Technologies, Inc., Asahi Kasei Corporation (ZOLL Medical Corporation), Qardio, Inc., Otsuka Holdings Co., Ltd. (Proteus Digital Health), CONMED Corporation, Sky Labs, MedtronicSAMSUNG, Baxter (Welch Allyn), Fitbit Inc., Apple Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CardioScan, CardioSTAT (Icentia Inc.), and Koninklijke Philips N.V., among others.

Recent Developments in the UK Wearable Cardiac Devices Market:

• In December 20222, Mindray introduces new wearable patient monitoring system, refining clinicia’s workflow to track patient conditions. “mWearTM” supports comprehensive and precise measurements of patient status, integrating 6 key vital signs powered by Anti-motion Algorithm, specialized health parameters, status indicators and time analysis. mWearTM features two monitoring modes, Wearable Mode and Continuous Mode, for caregivers to get patient status updates accordingly to the customize setting, and intelligently triggers emergencies and alarm escalations to ensure timely response to patient deterioration.
• In September 2022, Apple introduced Apple Watch Series 8 and the new Apple Watch SE, which bring ground breaking technology and performance, and important safety innovations to the two best-selling smartwatches. The new Apple Watch SE delivers the core Apple Watch experience, including Activity tracking, high and low heart rate notifications, and Emergency SOS, as well as the new Crash Detection feature.
• In August 2022, Medtronic plc announced the completion of its acquisition of Affera, Inc. This purchase broadens the company’s cardiac ablation offering by adding its inaugural cardiac mapping and navigation platform, which includes a distinct, fully integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.

UK Wearable Cardiac Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current UK Wearable Cardiac Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of UK Wearable Cardiac Devices Market in terms of revenue ($Million)
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the UK Wearable Cardiac Devices industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the UK Wearable Cardiac Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall UK Wearable Cardiac Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the UK Wearable Cardiac Devices Market are also analyzed.

Global UK Wearable Cardiac Devices Market Segmentation

By Component

• Holter monitors
• Patch
• Defibrillator
• Smart Watches
• Others

By Enterprise Size

• Home Healthcare
• Remote Patient Monitoring
• Sports And Fitness
• Others

By End-user

• Hospitals
• Retail Pharmacies
• Academic Institutes
• Others

By Region

• England
• Wales
• Scotland
• Ireland

Key Players

• iRhythm Technologies Inc
• Welch Allyn (Hillrom Services Inc
• ZOLL Medical Corporation
• Qardio Inc
• Proteus Digital Health
• CONMED Corporation
• NuVasive, Inc.
• Sky Labs
• Medtronic
• Samsung
• Fitbit Inc.
• Apple Inc.

New York, July 2023: According to a new research study by Global Insight Services (GIS), the endoscopy equipment market is expected to grow rapidly over the next 10 years to reach a value of more than USD $56.8 billion by 2032.

One of the most popular medical imaging devices in use today is the endoscope. Endoscopes are introduced by a physician or surgeon right into the organ, in contrast to conventional imaging tools. The endoscope has a camera and light on one end, which the doctor can use to view the visual in real time on a screen. To view detailed images of the intestinal wall and surrounding organs, ultrasound endoscopes use sound waves rather than cameras. These tools are also useful for inserting endoscopic implants in addition to imaging.

Request Sample Pages of this Research Report: 

https://www.globalinsightservices.com/request-sample/GIS10279/

Global Endoscopy Equipment Market: Key Drivers

Endoscopy operations are minimally invasive surgical procedures that involve the use of small tubes, miniature cameras, and surgical tools through one or more small incisions. The main benefits of endoscopic procedures include less pain, a shorter or no hospital stay, or fewer difficulties with pre- and post-surgery treatment. Because of this, these operations are more affordable, more successful, and safer than conventional open surgeries. Additionally, health insurance companies in wealthy nations including the United States, Canada, the United Kingdom, Germany, Australia, and a few Middle Eastern nations like the United Arab Emirates cover these operations. These elements contribute to both patients’ and doctors’ strong preferences for endoscopic operations. In the US, there are roughly 11.0 million colonoscopies conducted annually, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasonography exams, and 169,500 Endoscope Reprocessing procedures.

Report Findings

https://www.globalinsightservices.com/reports/endoscopy-equipment-market/

The endoscope segment is likely to account for the majority of the market share during the forecast period

The key factors attributing the growth of the market is higher adoption rate of these equipment coupled with rising preference of patients and doctors for minimally invasive procedures, and doctors for minimally invasive procedures, and ongoing advancements in endoscopy technologies.

The gastrointestinal endoscopy segment is likely to dominate the market during the forecast period

The largest share of the segment is attributed to the increasing geriatric population in the US, China, Japan and India and the rising incidence of colorectal cancer in younger adults, which leads to growing awareness of the target population of CRC screening.

The hospital segment is likely to dominate the endoscopy equipment market during the forecast period

The growing adoption of endoscope equipment in hospitals coupled with increasing government and private funding in the healthcare sector, as well as the greater availability of skilled healthcare professionals and technologically advanced facilities are boosting the growth of the market.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10279/

Competitive Landscape

The key players in the market are Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), JOHNSON & JOHNSON (US), Fujifilm Holdings Corporation (Japan), Medtronic Inc. (Ireland), Hoya Corporation (Japan), Nipro Corporation (Japan), Smith & Nephew Plc (UK), Richard Wolf GmbH (Germany), ConMed Corporation (US), Intuitive Surgical, Inc. (US), Cook Medical (US), Ambu A/S (Denmark), CapsoVision, Inc. (US), Fortimedix Surgical B.V. (Netherlands), B. Braun Melsungen AG (Germany), Medi-Globe (Germany), The Cooper Companies, Inc. (US), Dantschke Medizintechnik (Germany), Laborie Medical Technologies Inc. (Canada), Teleflex Incorporated (US), Cantel Medical Corp. (US), Carl Zeiss AG (Germany), and Arthrex, Inc. (US).

Global Endoscopy Equipment Market: Recent Developments

• February 2021, Olympus Corporation launched the SIF-H190 single balloon enteroscopy solution to reach deep into the small intestine.
• June 2021, Johnson & Johnson has launched the ENSEAL X1 curved Jaw Tissue Sealer, an advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissues.
• April 2021, Medtronic Plc, has launched the GI Genius Intelligent endoscopy module in the United States.
• June 2021, Smith & Nephew, has launched the Real Intelligence suite of enabling technology solutions, which includes the next-generation robotics platform and the CORI surgical system, in Australia and New Zealand.

Report Coverage:

•  The report offers a comprehensive quantitative as well as qualitative analysis of the current Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of Market in terms of revenue ($Million).
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the Market along with the current trends and future estimations to depict imminent investment pockets. The overall industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Market are also analyzed

Global Endoscopy Equipment Market Segmentation

By Product

• Endoscope
• Visualization System
• Other Endoscope Equipment
• Accessories

By Application

• Gastrointestinal Endoscopy
• Laparoscopy
• Obstetrics/Gynecology Endoscopy
• Arthroscopy
• Urology Endoscopy
• Bronchoscopy
• ENT Endoscopy
• Mediastinoscopy
• Other

By End User

• Hospitals
• Ambulatory Surgery Centers/Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Gastrointestinal Stent Market to Reach USD 796 Million by 2032, driven by the growth in incidences of gastrointestinal cancers across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global gastrointestinal stent market is expected to grow rapidly over the next 10 years to reach a value of more than USD 796 million by 2032.

Gastrointestinal (GI) stents are made to provide palliative care for a variety of illnesses that clog the GI tract. The recanalization of gastrointestinal (GI) malignancies and postoperative leak sealing are two important functions of GI stents. Drug-eluting devices, tissue modeling for benign disorders, and GI tract drainage/anastomosis are among more possible uses for GI stents. The rise in gastrointestinal malignancies and other digestive illnesses, changing lifestyles, rising healthcare spending on gastrointestinal treatments, and growing desire for less invasive surgery are all factors contributing to the growth of the global market for gastrointestinal stents.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10289/

Gastrointestinal Stent Market: Key Trends and Drivers

The increase in the incidence of gastrointestinal cancers, IBD, and other digestive diseases is propelling the growth of the market. One of the biggest causes of death in the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, and serious gastrointestinal disorders have sharply increased in recent years. According to the International Agency for Research on Cancer (IARC), gastrointestinal malignancies accounted for 35 percent of all cancer-related fatalities and 26 percent of the global burden of cancer incidence in 2018. The WHO estimates that stomach cancer caused 769,000 deaths worldwide in 2020, whereas gastrointestinal malignancies like colorectal cancer cause 935,000 deaths. 1.93 million new instances of colorectal cancer were detected worldwide in 2020, making it the third most frequent cancer overall.

Gastrointestinal Stent Market: Market Restraints and Challenges

The high cost of the procedure and limited reimbursement in developing countries is anticipated to hinder the growth of the market. Globally, the cost of healthcare has dramatically climbed in recent years, as have the costs of medical devices like GI stent. Approximately USD 43,798.06 is the average cost of an endoscopic stenting treatment, according to a study published by PubMed.gov in May 2021. In developing nations like India and Brazil, healthcare providers and payers have limited financial means to spend in such an expensive surgery. One of the main reasons why patients and doctors are reluctant to choose gastrointestinal stents is the fact that endoscopic stenting operations are seldom or never reimbursed by governments in most Asian nations. It is anticipated that the high price and lack of reimbursement in developing nations like India may restrict the use of gastrointestinal stent-related treatments by patients.

Gastrointestinal Stent Market Report Findings

https://www.globalinsightservices.com/reports/gastrointestinal-stent-market/

The biliary stents segment accounted for the largest share in 2022

Based on product, it is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents. The biliary stents segment accounted for the largest share in 2022. The biliary stent segment is anticipated to grow at the highest CAGR during the forecast period. One of the key drivers behind the expansion of the biliary stents market is the rising incidence of bile duct cancer and chronic liver disease. Additional important factors that are anticipated to promote the growth of this market segment during the projected period include the rising incidence of biliary disorders and the rise in the number of surgical procedures for the treatment of biliary diseases.

The self-expanding metal segment is anticipated to dominate the market during the forecast period

Based on material, it is segmented into self-expanding metal stents and plastic stents. The Self-expanding metal stents are further sub-segmented into nitinol, stainless steel, and other metal stents. The self-expanding metal segment is anticipated to dominate the market during the forecast period. Factors like the rising demand for self-expanding metal stents because of its benefits, including ease of insertion, a reduced risk of dislodgment or migration, and extended patency. Stainless steel, nitinol, cobalt-chromium, and platinum-chromium with or without coating are the typical materials used to make metal stents. Benign gastrointestinal leaks and perforations are treated with self-expanding metal stents. These stents serve as a support to maintain the digestive tract open and allow for simple, unhindered outflow of food and liquids.

The biliary diseases segment accounted for the majority of market share during the forecast period

Based on application, it is segmented into biliary diseases, irritable bowel syndrome, and gastrointestinal cancers. The biliary diseases segment accounted for the majority of market share during the forecast period. The gastrointestinal cancers segment is anticipated to have the highest share during the projection period. The rise in prevalence and incidence of gastrointestinal malignancies is thought to be the cause of this market segment’s expansion. For instance, the American Cancer Society’s Colorectal Cancer Facts & Figures 2020-2022 report estimates that in the US in 2020, 43,340 new cases of rectal cancer and 104,610 new instances of colon cancer would be detected.

The hospital end user segment is anticipated to dominate the market during the forecast period

Based on end user, it is segmented into hospitals & clinics, and ambulatory surgical centers. The hospital end user segment is anticipated to dominate the market during the forecast period. Due to the high volume of endoscopic retrograde cholangio-pancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures carried out in hospitals for a variety of disease indications, favorable reimbursement scenarios, and increased government initiatives to provide high-quality treatment for digestive disorders, this segment has a sizable market share.

North America had the biggest market share for gastrointestinal stents, followed by Europe and the Asia-Pacific region

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America had the biggest market share for gastrointestinal stents, followed by Europe and the Asia-Pacific region. The market in the Asia Pacific is anticipated to expand at the greatest CAGR over the forecast period. The APAC region’s market is growing primarily as a result of factors such as an aging population, an increase in gastrointestinal illnesses, a rise in per capita income and life expectancy, as well as increased investments by major market participants in the area.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10289/

Competitive Landscape

The key players studied in the global gastrointestinal stent market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), and Taewoong Medical (South Korea) among others.

Recent Developments in the Gastrointestinal Stent Market:

• November 2020, Boston Scientific Corporation has received 510(k) approval from the U.S. Food and Drug Administration and CE Mark approval to market its Wall Flex fully covered esophageal stent for the treatment of malignant esophageal strictures caused by esophageal cancer.
• October 2020, Olympus Corporation launched Hanaro Stent Espophagus TTS self-expanding metal stents made by MI-Tech and distributed exclusively through Olympus in the US.
• June 2019, Merit Medical System Inc. acquired Brightwater Medical Inc. has received the FDA clearance for the ConvertX biliary stent device.
• June 2018, Cook Medical entered into the US. The new deal comprises the Niti-S Esophageal Stent, the flagship product of Taewoong Medical’s Self-expandable line of metal GI stents.

Gastrointestinal Stent Market Report Coverage:

•  The report offers a comprehensive quantitative as well as qualitative analysis of the current Gastrointestinal Stent Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of Gastrointestinal Stent Market in terms of revenue ($Million).
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Gastrointestinal Stent industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the Gastrointestinal Stent Market along with the current trends and future estimations to depict imminent investment pockets. The overall Gastrointestinal Stent industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Gastrointestinal Stent Market are also analyzed

Global Gastrointestinal Stent Market Segmentation

By Product

• Biliary Stents
• Duodenal Stents
• Colonics Stents
• Pancreatic Stents
• Esophageal Stents

By Material

• Self-expanding Metal Stents
• Plastic Stents

By Application

• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers

By Region:

•  North America
  •  The U.S.
  • Canada
  •  Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  •  Italy
  • Netherlands
  • Sweden
  • Switzerland
  •  Denmark
  • Finland
  •  Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  •  Rest of Asia-Pacific
•  Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Boston Scientific Corporation (US)
• Cook Group (US)
• Medtronic plc. (Ireland)
• ELLA-CS, s.r.o. (Czech Republic)
• Becton, Dickinson and Company (US)
• Merit Medical Systems (US)
• CONMED Corporation (US)
• Cantel Medical (US)
• Olympus Corporation (Japan)
• Taewoong Medical (South Korea)

Global Diabetes Devices Market to Reach US$ 8.0 BN by 2032, driven by growth in medical applications: Global Insight Services

New York, July 2032: According to a new research study by Global Insight Services (GIS), the diabetes devices market is expected to grow rapidly over the next 10 years to reach a value of more than the US $8.0 billion by 2032.

Diabetes is a disorder that occurs when the blood glucose levels rise over normal levels, due to a defect in insulin production that controls glucose levels. Blood glucose acts as the main source of energy and can be obtained from the food we consume. Insulin, the pancreatic hormone maintains blood glucose levels. Defect in the synthesis of insulin in the body cannot regulate the blood glucose level and causes diabetes. The Blood glucose level range in a normal individual is 70 – 100 mg/dL and in a diabetic patient it raises up to 80 – 130 mg/dL. Diabetes care devices are employed to monitor the glucose levels of a diabetic patient. A continuous glucose monitor (CGM) is a medical device that tracks and monitors the blood glucose of a diabetic patient during the day.

Request Sample Pages of this Research Report: 

https://www.globalinsightservices.com/request-sample/GIS10117/

Global Diabetes Devices Market: Key Drivers

The key factors such as an increase in the incidence of diabetes owing to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to WHO, in 2016, over 1.9 billion adults were overweight, of which, around 650 million people were obese. Risk factors, like obesity and overweight, are leading to a rise in the incidence of diabetes. Owing to that, risk factors like smoking, overweight, obesity, and high cholesterol levels are anticipated to boost the prevalence of diabetes, so fueling the need for diabetes devices.

Market Restraints and Challenges

The major factor hindering the growth of the market is that the blood glucose monitoring devices do not measure the exact level of glucose in the blood but give a range of blood glucose levels. Adding to these, the adverse effects related to some of the diabetes care devices are hindering the growth of the market.

Report Findings

https://www.globalinsightservices.com/reports/diabetes-devices-market/

The blood glucose monitoring systems segment is likely to dominate the market during the forecast period

Based on type, it is segmented into blood glucose monitoring systems. Self-monitoring blood glucose monitoring systems, continuous glucose monitoring systems, test strips/test papers, lancets/lancing devices, insulin delivery devices, insulin pumps, insulin pens, insulin syringes and needles, and diabetes management mobile applications. The blood glucose monitoring systems segment is likely to dominate the market during the forecast period. The key factors such as convenience, simplicity of use coupled with utility in providing real time insights related to diabetic conditions to patients and healthcare professionals for integrated diabetes management are boosting the market growth.

The hospitals & specialty clinics segment is likely to dominate the market during the forecast period

Based on end user, it is segmented into hospitals & specialty clinics, and self & home care. The hospitals & specialty clinics segment is likely to dominate the market during the forecast period. The key factors such as technological innovations coupled with a rising focus to reduce the chances of infections and accidental pricking to increase the growth of the market during the forecast period.

The North America region is likely to dominate the market during the forecast period

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market during the forecast period. High per capita income coupled with increasing healthcare spending are the key factors boosting the growth of the market during the forecast period. The large diabetic population and favorable reimbursement policies are also boosting the growth of the market.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10117/

Competitive Landscape

The key players in the diabetes devices market are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan), among others.

Recent Developments

• February 2020, Abbott received US FDA approval for the use of Free Style Libre 14-day Flash glucose monitoring systems in hospitals.
• February 2020, Insulet signed a commercialization agreement with DexCom Inc., to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.
• April 2020, Ypsomed entered into a partnership with DexCom, Inc. to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.
• January 2020, Life Scan entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sale of Life Scan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
• December 2019, Eli Lily and Company announced a global commercialization agreement to integrate DexCom, Inc., products into Lilly’s personalized diabetes management system, currently in development, to advance the treatment of diabetes.

Market Segments

By Type

• Blood glucose monitoring systems
• Self-monitoring blood glucose monitoring systems
• Continuous glucose monitoring systems
• Test strips/Test papers
• Lancets/Lancing devices
• Insulin delivery devices
• Insulin pumps
• Insulin pens
• Insulin syringes and needles
• Diabetes management mobile applications

By End User

• Hospitals & Specialty Clinics
• Self & Home Care

By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • Middle East
  • Africa